Introduction {#sec1}
============

Due to their applications in various fields of chemistry^[@ref1]^ as well as their uses in asymmetrical catalysis^[@ref2]^ and materials sciences^[@ref3]^ and their prevalence in naturally occurring molecules,^[@ref4]^ spiro compounds are of current interest.^[@ref5]^ Because of the presence of a quaternary carbon and fused rings in the spiro systems, their synthesis seems to be interesting from the point of view of the chemists. They are structurally diverse, and various methods have been developed for their synthesis in recent years.^[@ref5]^ The structures of some important and biologically active compounds containing spirocyclic rings are shown in [Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}.

![Examples of some biologically active spirocyclic compounds.](ao0c01934_0001){#fig1}

On the other hand, the isobenzofuran scaffolds, particularly phthalides (isobenzofuran-1(3*H*)-ones), exist in many natural and synthetic biologically active materials and their derivatives display various biologically active properties as well as other uses including as colorants and perfumes.^[@ref6]^ In addition, many of their derivatives have been used as synthons for the synthesis of complex molecules.^[@ref7]^ Due to the chemical importance and biological applications of isobenzofurans, their synthesis has attracted the interest of various research groups and quite a lot of methods have been developed. Someof the most recently reported methods include the following: Montmorillonite K-10-, ZrOCl~2~--8H~2~O-, and silica-supported Preyssler-nanoparticle-catalyzed condensation and lactonization of phthalaldehydic acid (2-carboxybenzaldehyde) with methylaryl and cyclic ketones;^[@ref8]^ magnetic-nanoparticle-supported 1-methyl-3-(propyl-3-sulfonic acid)imidazolium triflate-catalyzed reaction of phthalaldehydes, and methylaryl ketones;^[@ref9]^ insertion of aldehydes into a C--H bond of aromatic ketimines using a rhenium complex, \[ReBr(CO)~3~(thf)\]~2~;^[@ref10]^ coupling of *o*-alkynylbenzoyl derivatives with Fischer carbene complexes;^[@ref11]^ Pd-catalyzed oxidative intramolecular C--H functionalization reactions of 3-(2-(hydroxymethyl)aryl)-*N*-methyl-*N* arylpropiolamides;^[@ref12]^[l]{.smallcaps}-proline-catalyzed cascade Michael-aldol reaction of 4-hydroxy-3-alkyl-5*H*-furan-2-ones with alkyl vinyl ketones;^[@ref13]^ silica sulfuric acid- and molecular-iodine-mediated oxidative cleavage of 4b,9b-dihydroxy-4*bH*-indeno\[1,2-*b*\]benzofuran-10(9*bH*)-ones;^[@ref14]^ Sc(OTf)~3~-catalyzed reaction of *o*-dicarbonylbenzenes and hydrosilane;^[@ref15]^ chemoenzymatic bioreduction of 2-acetylbenzonitriles;^[@ref16]^ \[Cu\]- and \[Pd\]-catalyzed intermolecular cyanation or carbonylation of *o*-bromobenzyl alcohols;^[@ref17]^ the reaction of 2-cyanobenzaldehydes with nucleophiles, such as organolithiums or lithium enolates of *tert*-butyl acetate and *N*,*N*-dimethylacetamide;^[@ref18]^ nucleophilic addition of alkynyllithium to benzocyclobutenone and subsequent oxidative ring cleavage of the prepared bicyclo\[4.2.0\]octatrien;^[@ref19]^ oxidation of indane derivatives using molecular oxygen and H~2~O~2~ in subcritical water;^[@ref20]^ trifluoroacetic acid-mediated lactonization of *tert*-butyl 2-(1,3-dioxol-2-yl)- or 2-(1,3-dioxan-2-yl)benzoates;^[@ref21]^ and reductive hydroiodination of 2-alkynylbenzoates through an I~2~/PPh~3~/H~2~O-triggered cascade reaction.^[@ref22]^

However, careful investigation of these methods reveals that most of them suffer from drawbacks such as using expensive reagents and catalysts and dealing with multistep synthetic strategies with low reaction yields. Therefore, the development of sustainable green synthetic methods for the production of these compounds is of great importance and is an active area of the organic research.^[@ref23]^

We have contributed to the development of new pathways toward the synthesis of spirocyclic compounds containing isobenzofurane motifs by the employment of simple starting materials such as ninhydrin, phenols,^[@cit24a]^ and β--diketones^[@cit24b]^ ([Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}, eqs 1 and 2). Accordingly, 3*H*,3′*H*-spiro\[benzofuran-2,1-isobenzofuran\]-3,3-diones and 5-methyl-3,3′-dioxo-3*H*,3′*H*-spiro\[furan-2,1′-isobenzofuran\]-3,3′-dione derivatives were efficiently synthesized under mild and green reaction conditions. In this line of research and in continuation of our efforts to develop new methods for the synthesis of organic compounds *via* oxidative cleavage of in situ generated cyclic vicinal diols,^[@ref24]−[@ref26]^ herein, we report the results of our investigations on the synthesis of various new spiro-isobenzofuran compounds starting from ninhydrin and 4-amino-1,2-naphthoquinones/2-amino-1,4-naphthoquinones ([Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}, eq 3).

![Our Previous and Present Studies on the Synthesis of Spiro-isobenzofuran Derivatives](ao0c01934_0005){#sch1}

Results and Discussion {#sec2}
======================

We found that a fast and clean reaction occurred between a preheated mixture of ninhydrin and 4-(phenylamino)naphthalene-1,2-dione (**1a**), followed by treatment with periodic acid at room temperature, producing 1-phenyl-3′*H*-spiro\[benzo\[*g*\]indole-2,1′-isobenzofuran\]-3,3′,4,5(1*H*)-tetraone (**2a**) in excellent yield ([Scheme [2](#sch2){ref-type="scheme"}](#sch2){ref-type="scheme"}).

![Our First Screening of the One-Pot Synthesis of Spiro\[benzo\[*g*\]indole-2,1′-isobenzofuran\] Derivatives (**2**)](ao0c01934_0006){#sch2}

We next focused on optimizing the reaction conditions using different solvents and temperatures, and the results are summarized in [Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}. In addition to acetic acid, some other solvents such as ethanol, acetonitrile, tetrahydrofuran (THF), ethyl acetate, and dimethylsulfoxide (DMSO) were also examined under various reaction temperatures. It was found that, however, the reaction showed good results using DMSO at 50 °C from the reaction time and yield points of view, but acetic acid at 50 °C was still the best choice as the reaction medium (entry 2 vs entries 4--8). This is because of the fact that **2a** was not soluble in cooled acetic acid and thus it was quantitatively precipitated on cooling the reaction mixure down to room temperature, while the separation of product **2a** from DMSO was required for the addition of water and keeping the reaction mixture at low temperature overnight. On the other hand, raising the reaction temperature to 100 °C did not significantly improve the reaction time or yield of the reaction (entry 3). It is worth mentioning that the addition reaction of ninhydrin and 4-(phenylamino)naphthalene-1,2-dione (**1a**) should be carried out at 50 °C and periodic acid should be added after cooling down the reaction mixture to room temperature.

###### Optimization of the Reaction Conditions for the Synthesis of Compound **2a**

  entry   solvent   temperature (°C)   time (h)   yield (%)[a](#t1fn1){ref-type="table-fn"}
  ------- --------- ------------------ ---------- -------------------------------------------
  1       AcOH      25                 24         50
  2       AcOH      50                 3          90
  3       AcOH      100                2          87
  4       Ethanol   reflux             24         20
  5       EtOAc     reflux             24          
  6       CH~3~CN   reflux             24         20
  7       DMSO      50                 4          90
  8       DMSO      100                1.5        89

All yields are referred to as isolated yields.

The structure of spiro\[benzo\[*g*\]indole-2,1′-isobenzofuran\] (**2a**) was characterized based on our previous experience of the synthesis of spiro-isobenzofuran derivatives^[@ref12],[@ref13]^ and using spectroscopic as well as crystallographic data. For example, the most important absorption bands in the IR spectrum of **2a**, appearing as strong and distinct peaks at 1780.3, 1729.8, 1699.1, and 1640.9 cm^--1^, are due to the symmetric and asymmetric stretching of carbonyl groups of the furan, pyrrole, and quinone rings. In the ^1^H NMR spectra, the aromatic protons were resonated in their expected regions as doublets, complex multiplets, doublet of doublets, and doublet of triplets, with their characteristic fine structures. The ^13^C NMR spectrum exhibited five sharp signals in the δ 167.6--186.7 region, which were readily recognized as carbonyls and the *N*-connected fused carbon of the pyrrole and quinone moieties (C-**9b**).

The second fused carbon (C-**3a**) and the spiro carbon were resonated at δ 95.8 and δ 109.3, respectively; though it is not simple to exactly assign them. Other carbons showed their corresponding signals as 18 sharp and distinctive peaks between the chemical shifts of 124.5 and 142.0 ppm, which implied that the Ph-*N* bond of the aniline moiety has partially been restricted. The high resolution mass spectrum of **2a** displayed the \[M + H\]^+^ peak at *m*/*z* = 408.0888, which is in excellent agreement with the proposed structure.

To evaluate the feasibility of this new strategy for the synthesis of spiro\[benzo\[*g*\]indole-2,1′-isobenzofuran\] derivatives (**2**), various 4-(alkyl/arylamino)naphthalene-1,2-diones (**1**) were subjected to the one-pot reaction with ninhydrin and subsequent oxidation with periodic acid. All reactions were completed in less than 2.5 h, and the expected products were simply separated from the reaction mixture due to their precipitation from the reaction medium. They showed physical and spectral patterns as a structurally well-established product (**2a**); thus, their structures were proposed to be of spiro\[benzo\[*g*\]indole-2,1′-isobenzofuran\] derivatives (**2**).

All of the obtained products (**2**) had sufficient purity; however, they could be further purified by recrystallization from acetic acid, if necessary. Spiro\[benzo\[*g*\]indole-2,1′-isobenzofuran\] derivatives (**2**) were obtained in good to excellent yields (see [Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}). The procedure successfully works for aromatic as well as aliphatic and benzylic amines. Even amines bearing electro-attracting groups such as 2-furfurylamine and 2-pyridilamine were subjected to the reaction, and their corresponding products (**2l** and **2n**) were prepared in excellent yields.

###### Synthesis of Spiro\[benzo\[*g*\]indole-2,1′-isobenzofuran\] Derivatives (**2**) *via* a One-Pot Reaction of Ninhydrin, 4-(Alkyl/arylamino)naphthalene-1,2-diones (**1**), and Periodic Acid[a](#t2fn1){ref-type="table-fn"}

![](ao0c01934_0009){#fx1}

![](ao0c01934_0010){#fx2}

Reaction conditions. First step: ninhydrin, 1 mmol; 4-(alkyl/arylamino)naphthalene-1,2-diones (**1**), 1 mmol; acetic acid, 3 mL; and reaction temperature, 50 °C. All reactions were completed in about 2 h. Second step: 1 mmol H~5~IO~6~ was added to the above-cited reaction mixture at room temperature. All reactions were completed in less than 15 min. Yields, shown in parentheses are referred to as isolated yields based on initial amounts of ninhydrin or compound **1**.

Finally, the predicted structures of compounds **2** were undoubtedly established when the X-ray crystallographic data of product **2b** was successfully recorded from its appropriate single crystal ([Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}).

![Single-crystal X-ray structure of **2b** (CCDC 1506317).](ao0c01934_0002){#fig2}

From the ORTEP diagram of **2b** ([Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}), one can conclude that the aryl ring of the amine moiety of products **2** preferentially adopts a perpendicular configuration to the quinone ring, to minimize the repulsive force between the aryl ring and the quinone and isobenzofuran moieties ([Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}, rotamer I). This repulsion is reasonably maximum in a coplanar configuration of the aryl ring and the quinone moiety ([Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}, rotamer II). NMR data reveals that the rotational barrier of the aryl-*N* bond, arising from this repulsion, largely depends on the position and structure of the substituent on the aryl moiety. For example, ^1^H NMR spectra of compounds **2** show that this rotational barrier is very small for aniline and para-substituted anilines. On the other hand, some meta-substituted anilines have unexpectedly large rotational barriers. As a consequence, while aromatic protons of the aniline moiety of products **2a**--**d** are resonated as simplified AA′MM′ (or A~2~M~2~) patterns, the protons of ethyl and methoxy-substituents of **2f**--**h** as well as their aromatic protons clearly show the existence of two rotamers.

![Rotamers showing the preferred (**2(I)**) and nonpreferred (**2(II)**) orientations of the aryl ring of the amine moiety regarding quinone and isobenzofuran rings.](ao0c01934_0003){#fig3}

The aromatic and aliphatic parts of the room-temperature-recorded ^1^H NMR spectrum of product **2g** together with the aliphatic region of the spectrum of the same sample which is recorded at 65 °C (spectrum A in the blue box), are presented here ([Figure [4](#fig4){ref-type="fig"}](#fig4){ref-type="fig"}). [Figure [4](#fig4){ref-type="fig"}](#fig4){ref-type="fig"} clearly shows that all ^1^H NMR peaks of compound **2g** are duplicated, revealing that the product **2g** exists as a nearly equimolar mixture of two rotamers (**2g(I)**) and (**2g(II)**). More interestingly, the energy barrier for aryl-*N* bond rotation, due to the existence of *an m*-methoxy group, is large enough to distinguish between the rotamers **2g(I)** and **2g(II)**, even at temperatures as high as 65 °C. Decomposition of compound **2g** at higher temperatures forbids us to determine the coalescence temperature of methoxy signals (δ 3.56 and δ 3.75). Thus, the experimental calculation of Δ*G*^‡^ for aryl-*N* bond rotation failed. However, density functional theory (DFT) calculations at the B3LYP level of theory with 6-311+G\* as the basis set have shown that this barrier should be within 21--23 kcal mol^--1^, which is among the highest reported *N*-aryl bond rotational barriers.^[@ref27]−[@ref29]^

![Room-temperature-recorded ^1^H NMR spectrum of 1-(3-methoxyphenyl)-3′*H*-spiro\[benzo\[*g*\]indole-2,1′-isobenzofuran\] (**2g**). The inset (spectrum A in the blue box) shows the ^1^H NMR spectrum of methoxy hydrogens of **2g**, recorded at 65 °C.](ao0c01934_0004){#fig4}

In line with these interesting results, we decided to further study the reaction of 2-aminonaphthalene-1,4-diones (**3**) with ninhydrin followed by the addition of periodic acid to the reaction mixture. Also, in this case, we found that spiro\[benzo\[*f*\]indole-2,1′-isobenzofuran\]-3,3′,4,9-tetraone derivatives (**4**) were prepared when a mixture of ninhydrin and 2-(alkyl/arylamino)naphthalene-1,4-diones (**3**) was subjected to a reaction with periodic acid ([Table [3](#tbl3){ref-type="other"}](#tbl3){ref-type="other"}). During our screening for the optimization of the solvent and reaction conditions, we found that the best conditions for the synthesis of compounds **4** were exactly the same as those used for the synthesis of compounds **2** ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}), meaning that the first step was quantitatively carried out in acetic acid at 50 °C and periodic acid should also be added after cooling the reaction mixture down to room temperature (see [Table [3](#tbl3){ref-type="other"}](#tbl3){ref-type="other"}). The procedure was successfully applied to a wide variety of 2-(alkyl/arylamino)naphthalene-1,4-diones (**3**). Thus, the results summarized in [Table [3](#tbl3){ref-type="other"}](#tbl3){ref-type="other"} show that the corresponding spiro\[benzo\[*f*\]indole-2,1′-isobenzofuran\]-3,3′,4,9-tetraone derivatives (**4**) were obtained in good to excellent yields.

###### One-Pot Synthesis of Spiro\[benzo\[*f*\]indole-2,1′-isobenzofuran\]-3,3′,4,9-tetraone Derivatives (**4**) by the Reaction of Ninhydrin, 2-(Alkyl/arylamino)naphthalene-1,4-diones (**3**), and Periodic Acid[a](#t3fn1){ref-type="table-fn"}

![](ao0c01934_0011){#fx3}

![](ao0c01934_0012){#fx4}

Reaction conditions. First step: ninhydrin, 1 mmol; 2-(alkyl/arylamino)naphthalene-1,4-diones (**3**), 1 mmol; acetic acid, 3 mL; and reaction temperature, 50 °C. All reactions were completed in about 3 h. Second step: 1 mmol H~5~IO~6~ was added to the above-cited reaction mixture at room temperature. All reactions were completed in less than 45 min. Yields shown in parentheses, are referred to as isolated yields based on initial amounts of ninhydrin or compounds **3**.

Mechanistically, based on the well-known chemistry of ninhydrin as a cyclic polyketone^[@ref30]^ and due to the potential 1,3-binucleophilic nature of enaminones such as 4-(alkyl/arylamino)naphthalene-1,2-diones (**1**),^[@ref31]^ one would expect the formation of 6b,11b-dihydroxybenzo\[*g*\]indeno\[1,2-*b*\]indole (**A**) ([Scheme [3](#sch3){ref-type="scheme"}](#sch3){ref-type="scheme"}) from the condensation reaction of ninhydrin with enaminones (**1**). To prove this claim, the diol intermediates **A** for products **2b** and **4e** were randomly isolated and their structures were characterized based on their spectroscopic data. Subsequently, the oxidative cleavage of compound **A** using periodic acid resulted in the formation of benzo\[*f*\]naphtho\[1,2-*b*\]azocines (**B**).^[@ref32]^ Due to the relatively strong attraction between *N* and the carbonyl group on its opposite side (C-8), which introduces more positive charge on the *N* atom, the compounds benzo\[*f*\]naphtho\[1,2-*b*\]azocines (**B**) are prone to hydrolysis to result in their corresponding 2-(2-benzo\[*g*\]indolyl)benzoic acids (**C**). Finally, products **2** are formed from the cyclization reaction of intermediates **C** passing through acid-accelerated formation of zwitterionic intermediates (**D**). In comparison with other solvents ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}), the shorter reaction time and more efficiency of the reactions in acetic acid revealed the necessity of acidic conditions for the formation of the intermediates **A** and **D**.

![Proposed Mechanism for the Synthesis of Spirobenzo\[*g*\]indole-2,1′-isobenzofurane Derivatives (**2**)](ao0c01934_0007){#sch3}

Compounds having phenazine substructures are among the most practically important natural products. Due to their various biological activities, they have been the subject of numerous studies. Accordingly, many biological activities such as antimalarial,^[@ref32]^ trypanocidal,^[@ref33]^ fungicidal,^[@ref34]^ antiplateletic,^[@ref35]^ and antituberculotic^[@ref36]^ are shown by the phenazine derivatives. Also, some phenazines and phenazine-type compounds such as clofazimine and promethazine are routinely used for the treatment of many diseases in clinical centers.^[@ref37]^ Moreover, phenazine derivatives are the basic structural substance for many dyes, such as the toluylene red, indulines, and safranines.^[@ref38]^ They also show some applications as basic materials of photosensitizers in photodynamic tumor therapy, due to their ability to provide singlet oxygen or hydroxy radicals near the tumor to selectively destroy the targeted tissue.^[@ref39],[@ref40]^

Motivated by these applications, we decided to examine the condensation reaction of spiro\[benzo\[*g*\]indole-2,1′-isobenzofuran\] derivatives **2** with diamines **5**. Surprisingly, we found that the reactions were rapidly performed using a variety of compounds **2** and diamines **5** in acetic acid at room temperature ([Table [4](#tbl4){ref-type="other"}](#tbl4){ref-type="other"}).

###### Quantitative and Highly Chemoselective Synthesis of Benzo/Dibenzophenazines (**6**) by the Room-Temperature Reaction of Spiro\[benzo\[*g*\]indole-2,1′-isobenzofuran\] Derivatives (**2**) and Aryldiamines (**5**) in Acetic Acid[a](#t4fn1){ref-type="table-fn"}

![](ao0c01934_0013){#fx5}

![](ao0c01934_0014){#fx6}

Reaction conditions. Spiro\[benzo\[*g*\]indole-2,1′-isobenzofuran\] derivatives (**2**), 1 mmol; aryldiamines (**5**), 1 mmol; and acetic acid, 3 mL at room temperature. All reactions were completed in less than 2 h. Yields mentioned in parentheses are referred to as isolated yields. For products **6e**--**h**, yields are referred to the mixture of two structural isomers.

As shown in [Table [4](#tbl4){ref-type="other"}](#tbl4){ref-type="other"}, the reaction is quantitatively carried out for benzenediamine **5a** and its derivatives, which bear electron-donating (**5b**) as well as electron-withdrawing groups (**5c**,**d**), and also for naphthalenediamine (**5e**). Therefore, their corresponding spiro\[benzo\[*a*\]pyrrolo\[2,3-*c*\]phenazine-2,1′-isobenzofuran\] derivatives (**6a**--**h**) and spiro\[dibenzo\[*a*,*i*\]pyrrolo\[2,3-*c*\]phenazine-2,1′-isobenzofurans\] (**6i**,**j**) were obtained in excellent yields ([Table [4](#tbl4){ref-type="other"}](#tbl4){ref-type="other"}). It is worth noticing that the products **6e**--**h** were formed as almost two structural isomers with respect to the positioning of the methyl, nitro, or carboxylic acid substituents on C-10 or C-11. Their compositions were calculated from their ^1^H NMR spectra as 1:1, 1:0.4, and 1:0.9 for products **6e**, **6f**, and **6h** respectively. Because of a more complex pattern and wide signal overlapping, the composition ratio calculation of **6g** isomers was not possible. Also, their exact structural characterization regarding the location of methyl, nitro, or carboxylic acid groups on C-10 or C-11 positions was not done.

Finally, we found that when ethylenediamine **5f** was subjected to this reaction, spiro\[benzo\[*f*\]pyrrolo\[2,3-*h*\]quinoxaline-2,1′-isobenzofuran\]-3,3′(1*H*)-diones (**9a**,**b**) were obtained *via* aromatization of their corresponding dihydro intermediates (**8a**,**b**) in excellent yields ([Scheme [4](#sch4){ref-type="scheme"}](#sch4){ref-type="scheme"}).

![Efficient Synthesis of Spiro\[benzo\[*f*\]pyrrolo\[2,3-*h*\]quinoxaline-2,1′-isobenzofuran\]-3,3′(1*H*)-diones (**9a**,**b**)](ao0c01934_0008){#sch4}

Conclusions {#sec3}
===========

In summary, we synthesized some new derivatives of spiro-isobenzofuran compounds by the sequential condensation/oxidation reaction of ninhydrin with 4-amino-1,2-naphthoquinones or 2-amino-1,4-naphthoquinones. All of the reactions were performed as one-pot reaction in two steps. The condensation step was carried out in acetic acid as a solvent at 70--100 °C, and the oxidation step was performed in the presence of H~5~IO~6~ at room temperature. Various derivatives of spiro\[benzo\[*g*\]indole-2,1′-isobenzofuran\]-3,3′,4,5(1*H*)-tetraones and spiro\[benzo\[*f\]*pyrrolo\[2,3-*h*\]quinoxaline-2,1′-isobenzofuran\]-3,3′(1*H*)-diones were synthesized in good to high yields. Moreover, further condensation of the synthesized spiro\[benzo\[*g*\]indole-2,1′-isobenzofuran\]-3,3′,4,5(1*H*)-tetraones with 1,2-aryldiamines as well as 1,2-alkyldiamines results in efficient and chemoselective synthesis of spiro\[benzo/dibenzo\[*a,i*\]pyrrolo\[2,3-*c*\]phenazine-2,1′-isobenzofuran\]-1,3′(3*H*)-diones and spiro\[benzo\[*f*\]pyrrolo\[2,3-*h*\]quinoxaline-2,1′-isobenzofuran\]-3,3′(1*H*)-diones, respectively, in high yields.

Experimental Section {#sec4}
====================

General Information {#sec4.1}
-------------------

The chemicals used in this work were purchased from Merck and Sigma-Aldrich and used without purification. The progress of the reaction and the purity of compounds were monitored by thin-layer chromatography (TLC) analytical silica gel plates (Merck 60 F250). Melting points were determined on an Electrothermal 9100 apparatus. IR spectra were recorded using a Shimadzu IR-470 spectrometer with KBr plates. ^1^H and ^13^C NMR spectra were recorded on a 400 MHz Bruker DRX-400 AVANCE spectrometer (^1^H NMR 300, 400, and 500 MHz; ^13^C NMR 75, 100, and 125 MHz), using DMSO-*d*~6~ as the solvent with tetramethylsilane (TMS) as the internal standard at room temperature. high-resolution mass spectrometry-electrospray ionization (HRMS-ESI) spectra were recorded on an Agilent 6450 spectrometer.

General Procedure for the Synthesis of Spiro\[benzo\[*g*\]indole-2,1′-isobenzofuran\]-3,3′,4,5(1*H*)-tetraones (**2**) {#sec4.2}
----------------------------------------------------------------------------------------------------------------------

A mixture of ninhydrin (1 mmol) and 4-amino-1,2-naphthoquinones (**1**) (1 mmol) in acetic acid (2 mL) was stirred at 50 °C for 2--3 h until all reactants were consumed (TLC, *n*-hexane/ethyl acetate: 1/1). The reaction mixture was cooled to room temperature, periodic acid (1 mmol) was added, and stirring was continued for additional 15 min. Pure products (**2**) were obtained by filtration of the reaction mixture and washing the precipitates by distilled water (2 × 3 mL). If required, more pure products could be obtained by either recrystallization from ethyl acetate or column chromatography.

General Procedure for the Synthesis of Spiro\[benzo\[*f*\]indole-2,1′-isobenzofuran\]-3,3′,4,9-tetraone Derivatives (**4**) {#sec4.3}
---------------------------------------------------------------------------------------------------------------------------

A mixture of ninhydrin (1 mmol) and 3-amino-1,4-naphthoquinones (**3**) (1 mmol) in acetic acid (2 mL) was stirred at 50 °C for 2--3 h until all reactants were consumed (TLC, *n*-hexane/ethyl acetate: 1/1). The reaction mixture was cooled to room temperature, periodic acid (1 mmol) was added and stirring was continued for additional 45 min. Pure products (**4**) were obtained by filtration of the reaction mixture and washing the precipitates by distilled water (2 × 3 mL). If required, more pure products could be obtained by either recrystallization from ethyl acetate or column chromatography.

General Procedure for the Synthesis of Spiro\[benzo\[*a*\]pyrrolo\[2,3-*c*\]phenazine-2,1′-isobenzofuran\]-1,3′(3*H*)-diones (**6**) or Spiro\[benzo\[*g*\]indole-2,1′-isobenzofuran\]-3,3′,4,5(1*H*)-tetraones Derivatives (**9**) {#sec4.4}
-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

A mixture of spiro\[benzo\[*g*\]indole-2,1′-isobenzofuran\]-3,3′,4,5(1*H*)-tetraones (**2**) (1 mmol) and 1,2-aryldiamines (**5a**--**e**) or ethylenediamine (**5f**) (1 mol) in acetic acid (1 mL) was stirred for 1 h. After the completion of the reaction, as monitored by TLC, the reaction mixture was filtered and the resulting precipitate was washed with cooled acetic acid to obtain the pure products **6** or **9**.

### 1-Phenyl-3′*H*-spiro\[benzo\[*g*\]indole-2,1′-isobenzofuran\]-3,3′,4,5(1*H*)-tetraone (**2a**) {#sec4.4.1}

Yellow powder; mp \> 250 °C; IR (KBr): 1780.3, 1729.8, 1699.1, 1640.9 cm^--1^; ^1^H NMR (400 MHz, DMSO-*d*~6~) δ 6.89 (d, *J* = 7.6 Hz, 1H, arom), 7.21 (d, *J*~1~ = 8.0 Hz, 1H, arom), 7.38 (dt, *J*~1~ = 8.4 Hz, *J*~2~ = 1.2 Hz, 1H, arom), 7.45--7.65 (m, 4H, arom), 7.72 (dt, *J*~1~ = 7.5 Hz, *J*~2~ = 4 Hz, 1H, arom), 7.85--7.90 (m, 2H, arom), 7.91 (d, *J* = 7.6 Hz, 1H, arom), 8.07 (d, *J* = 7.6 Hz, 1H, arom), 8.21 (dd, *J*~1~ = 8.0 Hz, *J*~2~ = 1.2 Hz, 1H, arom); ^13^C NMR (100 MHz, DMSO-*d*~6~) δ (C-*spiro* and C~quinoxaline~=(CO)~2~): 95.8 109.3, aromatic carbons: 124.5, 126.1, 126.2, 126.3, 128.7, 128.8, 129.1, 130.2, 130.6, 131.0, 131.1, 132.6, 134.2, 134.6, 135.7, 135.8, 136.5, 142.0, (C~qunoxaline~--*N*) and carbonyl carbons: 167.6, 171.7, 174.5, 180.7, 186.8; HRMS (ESI) calcd for C~25~H~14~NO~5~ \[M + H\]^+^: 408.0866; found: 408.0888.

### 1-(4-Bromophenyl)-3′*H*-spiro\[benzo\[*g*\]indole-2,1′-isobenzofuran\]-3,3′,4,5(1*H*)-tetraone (**2b**) {#sec4.4.2}

Yellow powder; mp \> 250 °C; IR (KBr): 1800.7, 1791.7, 1723.1, 1695.3, 1652.9, 1633.3 cm^--1^; ^1^H NMR (400 MHz, DMSO-*d*~6~) δ 6.98 (d, *J* = 8.1 Hz, 1H, arom), 7.16 (d, *J* = 8.5 Hz, 1H, arom), 7.48 (d, *J* = 8.5 Hz, 1H, arom), 7.60 (d, *J* = 7.6 Hz, 1H, arom), 7.66 (t, *J* = 8.1 Hz, 1H, arom), 7.70--7.79 (m, 2H, arom), 7.80--7.98 (m, 3H, arom), 8.02 (d, *J* = 7.8 Hz, 1H, arom), 8.19 (d, *J* = 7.6 Hz, 1H, arom); ^13^C NMR (100 MHz, DMSO-*d*~6~) δ (C-*spiro* and C~quinoxaline~=(CO)~2~): 95.7, 109.5, aromatic carbons: 124.2, 124.4, 126.0, 126.1, 126.3, 128.9, 130.2, 130.7, 131.0, 132.8, 133.7, 134.2, 134.4, 134.5, 135.2, 135.7, 136.6, 141.8, (C~qunoxaline~--*N*) and carbonyl carbons: 167.4, 171.8, 174.7, 180.6, 186.7; HRMS (ESI) calcd for C~25~H~13~BrNO~5~ \[M + H\]^+^: 485.9972; found: 485.9978.

### 1-(4-Iodophenyl)-3′*H*-spiro\[benzo\[*g*\]indole-2,1′-isobenzofuran\]-3,3′,4,5(1*H*)-tetraone (**2c**) {#sec4.4.3}

Yellow solid; mp \> 250 °C; IR (KBr): 1801.5, 1794.3, 1728.8, 1717.5, 1693.5, 1654.1, 1632.7 cm^--1^; ^1^H NMR (400 MHz, DMSO-*d*~6~) δ ^1^H NMR (400 MHz, DMSO-*d*~6~) δ 6.99 (dd, *J*~1~ = 6.6 Hz, *J*~2~ = 2.1 Hz, 2H, arom), 7.31 (dd, *J*~1~ = 6.7 Hz, *J*~2~ = 2.0 Hz, 1H, arom), 7.65 (t, *J* = 6.2 Hz, 1H, arom), 7.70--7.77 (m, 2H, arom), 7.87--7.94 (m, 4H, arom), 8.01 (d, *J* = 6.2 Hz, 1H, arom), 8.19 (d, *J* = 6.2 Hz, 1H, arom); ^13^C NMR (100 MHz, DMSO-*d*~6~) δ (C*-spiro*, C~quinoxaline~=(CO)~2~ and C-I): 95.7 97.8, 109.5, aromatic carbons: 124.4, 126.0, 126.1, 126.3, 128.8, 130.2, 130.5, 130.7, 132.7, 133.9, 134.4, 134.5, 135.7, 136.5, 139.5, 140.0, 141.9, (C~qunoxaline~--*N*) and carbonyl carbons: 167.4, 171.8, 174.6, 180.6, 186.7. HRMS (ESI) calcd for C~25~H~13~INO~5~ \[M + H\]^+^: 533.9833; found: 533.9920.

### 1-(*p*-Tolyl)-3′*H*-spiro\[benzo\[*g*\]indole-2,1′-isobenzofuran\]-3,3′,4,5(1*H*)-tetraone (**2d**) {#sec4.4.4}

Yellow solid; mp \> 250 °C; IR (KBr): 1791.8, 1727.3, 1698.8, 1639.5, 1577.1 cm^--1^; ^1^H NMR (400 MHz, DMSO-*d*~6~) δ 2.30 (s, 3H, CH~3~), 6.94 (d, *J* = 7.6 Hz, 1H, arom), 7.07 (dd, *J*~1~ = 8.2 Hz, *J*~2~ = 2.4 Hz, 1H, arom), 7.18 (dd, *J*~1~ = 8.0 Hz, *J*~2~ = 1.2 Hz, 1H, arom), 7.36 (dd *J*~1~ = 8.0 Hz, *J*~2~ = 1.6 Hz, 1H, arom), 7.41 (dd, *J*~1~ = 8.0 Hz, *J*~2~ = 2.4 Hz, 1H, arom), 7.61 (dt, *J*~1~ = 7.6 Hz, *J*~2~ = 1.6 Hz 1H, arom), 7.72 (dt, *J*~1~ = 7.4 Hz, *J*~2~ = 0.8 Hz, 1H, arom), 7.85--7.96 (m, 3H, arom), 8.06 (d, *J* = 8 Hz, 1H, arom), 8.20 (dd, *J*~1~ = 7.6 Hz, *J*~2~ = 1.2 Hz 1H, arom); ^13^C NMR (100 MHz, DMSO-*d*~6~) δ 21.2 (CH~3~), (C-*spiro* and C~quinoxaline~=(CO)~2~): 95.8, 109.2, aromatic carbons: 124.4, 126.1, 126.2, 126.3, 128.4, 128.7, 128.7, 130.2, 131.1, 131.6, 132.6, 133.1, 134.3, 134.6, 135.6, 136.5, 140.8, 142.1, (C~qunoxaline~--*N*) and carbonyl carbons: 167.6, 171.6, 174.4, 180.7, 186.8. HRMS (ESI) calcd for C~26~H~16~NO~5~ \[M + H\]^+^: 422.1023; found: 422.1025.

### 1-(3,5-Dimethylphenyl)-3′*H*-spiro\[benzo\[*g*\]indole-2,1′-isobenzofuran\]-3,3′,4,5(1*H*)-tetraone (**2e**) {#sec4.4.5}

Yellow solid; mp \> 250 °C; IR (KBr): 1787.8, 1710.2, 1621.3, 1578.5 cm^--1^; ^1^H NMR (400 MHz, DMSO-*d*~6~) δ 2.10 (s, 3H, CH~3~), 2.30 (s, 3H, CH~3~), 6.91--6.95 (broad peak, 1H, arom), 7.08--7.12 (broad peak, 1H, arom), 7.13--7.17 (broad peak, 1H, arom), 7.33 (d, *J* = 8.0 Hz, 1H, arom), 7.74 (dd, *J*~1~ = 7.6 Hz, *J*~2~ = 1.2 Hz, 1H, arom), 7.84 (dt, *J*~1~ = 7.6 Hz, *J*~2~ = 1.2 Hz, 1H, arom), 7.95 (d, *J* = 7.6 Hz, 1H, arom), 8.00 (dd, *J*~1~ = 7.8 Hz, *J*~2~ = 0.8 Hz, 1H, arom), 8.07--8.12 (m, 1H, arom), 7.48 (d, *J* = 9.2 Hz, 1H, arom), 8.55 (dd, *J*~1~ = 9.4 Hz, *J*~2~ = 2.4 Hz, 1H, arom); ^13^C NMR (100 MHz, DMSO-*d*~6~) δ 21.1 (CH~3~), 21.2 (CH~3~), (C-*spiro* and C~quinoxaline~=(CO)~2~): 95.8, 109.2, aromatic carbons: 124.4, 125.9, 126.0, 126.1, 126.2, 126.3, 128.8, 130.1, 132.6, 134.2, 134.6, 135.7, 136.3, 139.9, 140.5, 142.1, (C~qunoxaline~--*N*) and carbonyl carbons: 167.6, 171.6, 174.3, 180.7, 186.8. HRMS (ESI) calcd for C~27~H~18~NO~5~ \[M + H\]^+^: 436.1179; found: 436.1174.

### 1-(3-Ethoxphenyl)-3′*H*-spiro\[benzo\[*g*\]indole-2,1′-isobenzofuran\]-3,3′,4,5(1*H*)-tetraone (**2f**) {#sec4.4.6}

Both ^1^H and ^13^C NMR spectra of this compound clearly show an exactly 1:1 mixture of two rotamers. Yellow solid; mp \> 250 °C; IR (KBr): 1782.0, 1729.5, 1701.1, 1647.5 cm^--1^; ^1^H NMR (400 MHz, DMSO-*d*~6~) δ 1.16 (t, *J* = 7.2 Hz, 3H, CH~3~), 1.30 (t, *J* = 7.2 Hz, 3H, CH~3~), 3.75 (dq, *J*~1~ = 9.8 Hz, *J*~2~ = 6.8 Hz, 1H, CH~2~-Me), 3.84 (dq, *J*~1~ = 9.8 Hz, *J*~2~ = 6.8 Hz, 1H, CH~2~-Me), 3.97 (dq, *J*~1~ = 9.8 Hz, *J*~2~ = 6.8 Hz, 1H, CH~2~-Me), 4.03 (dq, *J*~1~ = 9.8 Hz, *J*~2~ = 6.8 Hz, 1H, CH~2~-Me), 6.73 (ddd, *J*~1~ = 8 Hz, *J*~2~ = 2 Hz, *J*~3~ = 0.8 Hz, 1H, arom), 6.85 (t, *J* = 2.4 Hz, 1H, arom), 6.97--7.14 (m, 6H, arom), 7.27 (t, *J* = 8.0 Hz, 1H, arom), 7.44 (t, *J* = 8 Hz, 1H, arom), 7.63 (dt, *J*~1~ = 7.6 Hz, *J*~2~ = 1.2 Hz, 1H, arom), 7.64 (dt, *J*~1~ = 8.0 Hz, *J*~2~ = 1.6 Hz, 1H, arom), 7.70--7.76 (m, 2H, arom), 7.85--7.97 (m, 6H, arom), 8.01--8.09 (m, 2H, arom), 8.20 (dt, *J*~1~ = 7.6 Hz, *J*~2~ = 1.6 Hz, 2H, arom); ^13^C NMR (100 MHz, DMSO-*d*~6~) δ 14.6 (CH~3~), 14.8 (CH~3~), 63.9 (OCH~2~), 64.1 (OCH~2~), (C-*spiro* and C~quinoxaline~=(CO)~2~): 95.8, 95.9, 109.2, 109.3, aromatic carbons: 114.5, 114.9, 116.9, 117.6, 120.3, 120.7, 124.5, 124.6, 126.0, 126.1, 126.2, 126.3, 128.8, 128.9, 130.1, 130.2, 131.4, 131.9, 132.7, 134.3, 134.5, 134.6, 135.6, 135.7, 136.3, 136.4, 136.7, 136.8, 141.9, 142.1, 159.6, 160.0, (C~qunoxaline~--*N*) and carbonyl carbons: 167.6, 167.7, 171.6, 171.7, 174.5, 174.6, 180.7, 180.8, 186.7, 186.8; HRMS (ESI) calcd for C~27~H~18~NO~6~ \[M + H\]^+^: 452.1129; found: 452.1130.

### 1-(3-Methoxyphenyl)-3′*H*-spiro\[benzo\[*g*\]indole-2,1′-isobenzofuran\]-3,3′,4,5(1*H*)-tetraone (**2g**) {#sec4.4.7}

Both ^1^H and ^13^C NMR spectra of this compound clearly show a 1:1 mixture of two rotamers. Yellow solid; mp \> 250 °C; IR (KBr): 1792.1, 1726.8, 1699.8, 1649.8, 1640.5, 1600.8 cm^--1^; ^1^H NMR (400 MHz, DMSO-*d*~6~) δ 3.56 (s, 3H, OCH~3~), 3.74 (s, 3H, OCH~3~), 6.76 (ddd, *J*~1~ = 7.8 Hz, *J*~2~ = 1.6 Hz, *J*~3~ = 0.8 Hz, 1H, arom), 6.82 (t, *J* = 2.4 Hz, 1H, arom), 7.00--7.12 (m, 6H, arom), 7.29 (t, *J* = 8.0 Hz, 1H, arom), 7.47 (t, *J* = 8.0 Hz, 1H, arom), 7.63 (dt, *J*~1~ = 8.0 Hz, *J*~2~ = 1.2 Hz, 1H, arom), 7.64 (dt, *J*~1~ = 8.0 Hz, *J*~2~ = 1.2 Hz, 1H, arom), 7.73 (dt, *J*~1~ = 7.2 Hz, *J*~2~ = 0.4 Hz, 1H, arom), 7.73 (dt, *J*~1~ = 7.6 Hz, *J*~2~ = 0.8 Hz, 1H, arom), 7.76--7.95 (m, 6H, arom), 8.01--8.10 (m, 2H, arom), 8.20 (dt, *J*~1~ = 7.6 Hz, *J*~2~ = 1.2 Hz, 2H, arom); ^13^C NMR (100 MHz, DMSO-*d*~6~) δ 55.9 (OCH~3~), 56.0 (OCH~3~), (C*-spiro* and C~quinoxaline~=(CO)~2~): 95.8, 109.2 2, 109.3 aromatic carbons: 114.3, 114.8, 116.2, 116.6, 120.5, 120.9, 124.5, 124.6, 126.0, 126.1, 126.2, 126.3, 128.8, 128.9, 130.1, 130.2, 131.4, 131.9, 132.6, 132.7, 134.2, 134.3, 134.5, 134.6, 135.6, 135.7, 136.3, 136.4, 136.7, 136.8, 141.9, 142.0, 160.4, 160.7, (C~qunoxaline~--*N*) and carbonyl carbons: 167.6, 167.7, 171.6, 171.7, 174.5, 174.6, 180.6, 180.7, 186.7, 186.8; HRMS (ESI) calcd for C~26~H~16~NO~6~ \[M + H\]^+^: 438.0972; found: 438.0990.

### 1-(2,5-Dimethoxyphenyl)-3′*H*-spiro\[benzo\[*g*\]indole-2,1′-isobenzofuran\]-3,3′,4,5(1*H*)-tetraone (**2h**) {#sec4.4.8}

Both ^1^H and ^13^C NMR spectra of this compound clearly show about a 1:0.7 mixture of two rotamers. Yellow solid; mp \> 250 °C; IR (KBr): 1787.5, 1726.2, 1698.2, 1639.8, 1601.1, 1578.4 cm^--1^; ^1^H NMR (300 MHz, DMSO-*d*~6~) δ 3.41 (s, 3 H, OCH~3~), 3.44 (s, 2.1H, OCH~3~), 3.62 (s, 2.1H, OCH~3~),3.71 (s, 3 H, OCH~3~), 6.32 (d, *J* = 3Hz, 0.68 H, arom), 6.92--7.11 (m, 3.7H, arom), 7.16--7.28 (m, 2.4H, arom), 7.62--8.04 (m, 9.8H, arom), 8.10 (d, *J* = 7.5H, 0.8H, arom), 8.21 and 8.22 (two overlapped dd, *J*~1~ = 7.8 and 7.5 Hz, *J*~2~ = 1.2 and 1.2 Hz, 1.7H, arom); ^13^C NMR (75 MHz, DMSO-*d*~6~) δ 55.9 (OCH~3~), 56.1 (OCH~3~), 56.2 (OCH~3~), 57.2 (OCH~3~), (C-spiro): 95.8, 96.1, (C~quinoxaline~=(CO)~2~ and aromatic carbons): 108.7, 109.3, 114.2, 114.4, 114.5, 115.5, 117.4, 117.5, 124.2, 124.4, 124.5, 125.8, 126.0, 126.2, 126.3, 126.4, 126.5, 126.6, 127.0, 127.2, 130.1, 130.2, 132.6, 132.8, 134.0, 134.7, 135.8, 135.9, 136.6, 141.6, 142.6, 148.5, 150.1, 153.4, 153.7, (C~qunoxaline~--*N*) and carbonyl carbons: 167.6, 167.8, 171.4, 171.6, 174.7, 175.3, 180.3, 186.7, 187.0; HRMS (ESI) calcd for C~27~H~18~NO~7~ \[M + H\]^+^: 468.1078; found: 468.1124.

### 1-(3,4-Dimethylphenyl)-3′*H*-spiro\[benzo\[*g*\]indole-2,1′-isobenzofuran\]-3,3′,4,5(1*H*)-tetraone (**2i**) {#sec4.4.9}

Both ^1^H and ^13^C NMR spectra of this compound clearly show nearly a 3:2.4 mixture of two rotamers. Yellow solid; mp \> 250 °C; IR (KBr): 1794.8, 1724.4, 1698.3, 1638.6 cm^--1^; ^1^H NMR (400 MHz, DMSO-*d*~6~) δ 1.99--2.03 (broad peak, 1.7H, 2 × CH~3~ of the minor rotamer), 2.20 (s, 3H, CH~3~ of the major rotamer), 2.21 (s, 3H, CH~3~ of the major rotamer), 6.85--6.99 (m, 2.56H, arom), 7.11 (d, *J* = 6.4 Hz, 0.64H, arom), 7.24 (dd, *J*~1~ = 6.3Hz, *J*~2~ = 1.8 Hz, 0.56H, arom), 7.26--7.34 (m, 1.28H, arom), 7.59 (dt, *J*~1~ = 6.3, *J*~2~ = 1.2 Hz, 1.28H, arom), 7.67--7.75 (m, 1.31H, arom), 7.79--7.97 (m, 3.96H, arom), 8.04 (d, *J* = 6.3 Hz, 1.28H, arom), 8.14--8.23 (m, 1.26H, arom); ^13^C NMR (100 MHz, DMSO-*d*~6~) δ 19.6 (CH~3~), 19.7 (CH~3~), 19.8 (CH~3~), 21.5 (CH~3~), (C-spiro and C~quinoxaline~=(CO)~2~): 95.8, 95.9, 109.1, aromatic carbons: 124.4, 125.9, 126.0, 126.1, 126.2, 126.3, 126.4, 126.5, 126.7, 128.7, 128.8, 129.1, 129.3, 130.2, 131.4, 131.8, 132.6, 132.7, 133.2, 133.3, 134.3, 134.6, 134.7, 135.6, 135.7, 136.3, 136.4, 138.9, 139.4, 139.6, 139.7, 142.1, 142.2, (C~qunoxaline~--*N*) and carbonyl carbons: 167.5, 167.6, 171.6, 172.5, 174.3, 178.1, 180.7, 186.8, 187.7; HRMS (ESI) calcd for C~27~H~18~NO~5~ \[M + H\]^+^: 436.1179; found: 436.1198.

### 1-(*o*-Tolyl)-3′*H*-spiro\[benzo\[*g*\]indole-2,1′-isobenzofuran\]-3,3′,4,5(1*H*)-tetraone (**2j**) {#sec4.4.10}

Yellow solid; mp \> 250 °C; IR (KBr): 1780.8, 1731.9, 1686.1, 1645.2, 1591.6 cm^--1^; ^1^H spectra of this compound show a mixture of two rotamers; however, because of highly overlapping signals, their composition ratio was not calculated. ^1^H NMR (300 MHz, DMSO-*d*~6~) just for the major rotamer is reported; δ 2.29 (s, 3H, CH~3~), 6.84 (d, *J* = 7.5 Hz, arom), 6.93 (d, *J* = 7.8, 1H, arom), 7.18 (dt, *J*~1~ = 5.9 Hz, *J*~2~ = 1.5 Hz, 1H, arom), 7.42--7.52 (m, 2H, arom), 7.59 (dt, *J*~1~ = 7.8 Hz, *J*~2~ = 1.2 Hz, 1H, arom), 7.79 (dt, *J*~1~ = 7.5 Hz, *J*~2~ = 0.6 Hz, 1H, arom), 7.87--8.96 (m, 2H, arom), 7.99 (dt, *J*~1~ = 7.5 Hz, *J*~2~ = 0.9 Hz, 1H, arom), 8.16--8.33 (m, 2H, arom); ^13^C NMR (75 MHz, DMSO-*d*~6~) δ 19.5 (CH~3~), (C-spiro and C~quinoxaline~=(CO)~2~): 95.3, 108.8, aromatic carbons: 124.2, 125.6, 125.7, 126.3, 126.5, 127.0, 129.1, 130.3, 132.6, 133.1, 133.4, 133.5, 133.8, 135.9, 136.4, 137.4, 137.9, 142.0, (C~qunoxaline~--*N*) and carbonyl carbons: 167.1, 167.8, 171.2, 178.3, 190.0; HRMS (ESI) calcd for C~26~H~17~NO~5~ \[M + H\]^+^: 422.1023; found: 422.0960.

### 1-(2-Chlorobenzyl)-3′*H*-spiro\[benzo\[*g*\]indole-2,1′-isobenzofuran\]-3,3′,4,5(1*H*)-tetraone (**2k**) {#sec4.4.11}

Orange solid; mp \> 250 °C; IR (KBr): 1792.3, 1728.9, 1691.6, 1645.5 cm^--1^; ^1^H NMR (400 MHz, DMSO-*d*~6~) δ 4.96 (d, *J* = 18.8 Hz, 1H, H-CH-N), 5.40 (d, *J* = 18.8 Hz, 1H, H-CH-N), 7.26--7.95 (m, 2H, arom), 7.46 (dd, *J*~1~ = 7.4 Hz, *J*~2~ = 2.0 Hz, 1H, arom), 7.53 (dd, *J*~1~ = 7.0 Hz, *J*~2~ = 2.4 Hz, 1H, arom), 7.79 (t, *J* = 8.0 Hz, 2H, arom), 7.84--7.96 (m, 4H, arom), 8.02 (d, *J* = 7.2 Hz, 1H, arom), 8.24 (dd, *J*~1~ = 7.6 Hz, *J*~2~ = 1.2 Hz, 1H, arom); ^13^C NMR (100 MHz, DMSO-*d*~6~) δ 47.8 (CH~2~), (C-*spiro* and C~quinoxaline~=(CO)~2~): 96.2, 109.4, aromatic carbons: 124.1, 126.1, 126.4, 126.5, 128.1, 128.6, 129.0, 130.0, 130.1, 130.5, 131.7, 132.5, 132.8, 134.3, 134.9, 135.8, 136.3, 141.6, (C~qunoxaline~--*N*) and carbonyl carbons: 167.5, 171.4, 175.6, 180.6, 186.6; HRMS (ESI) calcd for C~26~H~15~ClNO~5~ \[M + H\]^+^: 456.0633; found: 456.0641.

### 1-Phenethyl-3′*H*-spiro\[benzo\[*g*\]indole-2,1′-isobenzofuran\]-3,3′,4,5(1*H*)-tetraone (**2l**) {#sec4.4.12}

Orange solid; mp \> 250 °C; IR (KBr):1787.5, 1726.2, 1698.1, 1639.8, 1601.1, 1578.4 cm^--1^; ^1^H NMR (400 MHz, DMSO-*d*~6~) δ 2.86 (ddd, *J*~1~ = 12.8 Hz, *J*~2~ = 11.2 Hz, *J*~3~ = 1.6 HZ, 1H, H-CH-Ph), 3.05 (ddd, *J*~1~ = 12.8 Hz, *J*~2~ = 10.8 Hz, *J*~3~ = 4.8 HZ, 1H, H-CH-Ph), 3.88 (ddd, *J*~1~ = 16.0 Hz, *J*~2~ = 10.6 Hz, *J*~3~ = 5.3 Hz, 1H, H-CH-N), 4.17 (ddd, *J*~1~ = 16.0 Hz, *J*~2~ = 10.6 Hz, *J*~3~ = 5.3 Hz, 1H, H-CH-N), 7.04--7.10 (m, 2H, arom), 7.19--7.31 (m, 3H, arom), 7.83--7.98 (m, 3H, arom), 8.02--8.09 (m, 2H, arom), 8.14 (d, *J* = 7.6 Hz, 1H, arom), 8.24--8.29 (m, 1H, arom), 8.39--8.45 (m, 1H, arom); ^13^C NMR (100 MHz, DMSO-*d*~6~) δ 35.4 (CH~2~), 47.4 (CH~2~), (C-*spiro* and C~quinoxaline~=(CO)~2~): 96.1, 108.9, aromatic carbons: 124.0, 126.3, 126.6, 126.7, 127.4, 129.0, 129.1, 129.4, 130.4, 132.9, 134.4, 135.2, 135.8, 136.5, 137.1, 142.1, (C~qunoxaline~--*N*) and carbonyl carbons: 167.6, 171.2, 174.8, 180.9, 186.5. HRMS (ESI) calcd for C~28~H~17~NO~5~ \[M + H\]^+^: 436.1179; found: 436.1205.

### 1-(Pyridin-2-yl)-3′*H*-spiro\[benzo\[*g*\]indole-2,1′-isobenzofuran\]-3,3′,4,5(1*H*)-tetraone (**2m**) {#sec4.4.13}

Orange solid; mp \> 250 °C; IR (KBr): 1787.5, 1729.6, 1699.3, 1638.7, 1602.0, 1586.1 cm^--1^; ^1^H NMR (400 MHz, DMSO-*d*~6~) δ 6.84 (s, 1H, arom), 7.16--7.58 (m, 2H, arom), 7.62 (t, *J* = 8.0 Hz, 1H, arom), 7.71 (t, *J* = 7.6 Hz, 1H, arom), 7.76--7.87 (m, 2H, arom), 7.90 (t, *J* = 7.6 Hz, 1H, arom), 7.96 (m, 2H, arom), 8.20 (d, *J* = 7.6 Hz, 1H, arom), 8.42 (s, 1H, arom); ^13^C NMR (100 MHz, DMSO-*d*~6~) δ (C-*spiro* and C~quinoxaline~=(CO)~2~): 95.6, 110.6, aromatic carbons: 122.9, 124.2, 125.7, 126.0, 126.1, 127.5, 128.6, 130.1, 132.5, 133.1, 134.1, 134.5, 136.2, 143.7, 149.7, 150.5, (C~qunoxaline~--*N*) and carbonyl carbons: 167.6, 172.1, 174.9, 180.0, 187.1. HRMS (ESI) calcd for C~25~H~14~NO~5~ \[M + H\]^+^: 409.0819; found: 409.0825

### 1-Phenyl-3′*H*-spiro\[benzo\[*f*\]indole-2,1′-isobenzofuran\]-3,3′,4,9(1*H*)-tetraone (**4a**) {#sec4.4.14}

Orange solid; mp 208--210 °C; IR (KBr): 1736.0, 1698.0, 1621.6, 1543.1 cm^--1^; ^1^H NMR (500 MHz, DMSO-*d*~6~) δ 7.24--7.37 (m, 4H, arom), 7.62--7.76 (m, 2H, arom), 7.84--7.92 (m, 3H, arom), 7.94--8.00 (m, 2H, arom), 8.03 (d, *J* = 7.9 Hz, 1H, arom), 8.14 (d, *J* = 7.6 Hz, 1H, arom); ^13^C NMR (125 MHz, DMSO-*d*~6~) δ (C-*spiro* and C~quinoxaline~=(CO)~2~): 95.3, 108.9 9, aromatic carbons: 124.1, 125.9, 126.2, 126.5, 127.0, 129.1, 129.4, 129.5, 132.5, 133.4, 133.5, 133.8, 135.6, 135.9, 136.5, 141.9, (C~qunoxaline~--*N*) and carbonyl carbons: 167.1, 167.7, 177.2, 178.3, 189.9; HRMS (ESI) calcd for C~25~H~14~NO~5~ \[M + H\]^+^: 408.0866; found: 408.0870.

### 1-(3,4-Dimethoxyphenyl)-3′*H*-spiro\[benzo\[*f*\]indole-2,1′-isobenzofuran\]-3,3′,4,9(1*H*)-tetraone (**4b**) {#sec4.4.15}

Orange powder; mp \> 240 °C; IR (KBr) 1799.6, 1725.0, 1693.8, 1666.0, 1650.9, 1593.9 cm^--1^; ^1^H NMR (400 MHz, DMSO-*d*~6~) δ 3.25--3.67 (broad peak, 3H, overlapped OMe and HOD), 3.72 (s, 3H, OMe), 6.82--6.89 (broad peak, 1H, arom), 6.93--7.05 (broad peak, 1H, arom), 7.74 (t, *J* = 8.0 Hz, 1H, arom), 7.85--7.95 (m, 3H, arom), 7.97 (dd, *J*~1~ = 7.6 Hz, *J*~2~ = 1.6 Hz, 1H, arom), 8.00--8.10 (m, 2H, arom), 8.16 (dd, *J*~1~ = 7.6 Hz, *J*~2~ = 0.8 Hz, 1H, arom); ^13^C NMR (100 MHz, DMSO-*d*^6^) δ (ppm): 55.9 (CH~3~), 56.0 (CH~3~), (C-*spiro*): 95.4, (C~quinoxaline~=(CO)~2~ and aromatic carbons)108.8, 111.4, 112.4, 120.1, 120.3, 124.2, 125.9, 126.3, 126.5, 127.1, 128.0, 132.6, 133.5, 133.9, 135.9, 136.4, 142.1, 148.7, 149.5, (C~qunoxaline~--*N*) and carbonyl carbons: 167.0, 167.8, 177.1, 178.2, 189.9; HRMS (ESI) calcd for C~27~H~18~NO~7~ \[M + H\]^+^: 468.1078; found: 468.1077.

### 1-(*p*-Tolyl)-3′*H*-spiro\[benzo\[*f*\]indole-2,1′-isobenzofuran\]-3,3′,4,9(1*H*)-tetraone (**4c**) {#sec4.4.16}

Orange solid; mp \> 240 °C; IR (KBr): 1780.3, 1728.9, 1690.7, 1642.2, 1589.9, 1531.3, 1268.3 cm^--1^; ^1^H NMR (500 MHz, DMSO-*d*~6~) δ 2.24 (s, 3H, CH~3~), 7.02--7.28 (broad peak, 4H, arom), 7.71 (t, *J* = 7.5 Hz, 1H, arom), 7.85--7.91 (m, 3H, arom), 7.95--8.00 (m, 2H, arom), 8.03 (d, *J* = 7.9 Hz, 1H, arom), 8.13 (d, *J* = 7.7 Hz, arom); ^13^C NMR (75 MHz, DMSO-*d*~6~) δ 21.1 (CH~3~), (C-*spiro* and C~quinoxaline~=(CO)~2~): 95.3, 108.9, aromatic carbons: 124.1, 125.9, 126.2, 126.5, 127.0, 128.2, 129.9, 132.6, 132.9, 133.4, 133.5, 133.8, 135.9, 136.5, 139.1, 142.0, (C~quinoxaline~--*N*) and carbonyl carbons: 167.1, 167.7, 177.2, 178.3, 190.0; HRMS (ESI) calcd for C~26~H~16~NO~5~ \[M + H\]^+^: 422.1023; found: 422.1044.

### 1-(3,5-Dimethylphenyl)-3′*H*-spiro\[benzo\[*f*\]indole-2,1′-isobenzofuran\]-3,3′,4,9(1*H*)-tetraone (**4d**) {#sec4.4.17}

Orange solid; mp \> 240 °C; IR (KBr): 1775.9, 1728.8, 1685.4, 1660.9, 1644.4, 1609.3, 1532.2 cm^--1^; ^1^H NMR (500 MHz, DMSO-*d*~6~) δ 1.90--2.50 (broad peak, 6H, 2 × CH~3~), 6.70--7.16 (broad peak involving a singlet, 3H, arom), 7.72 (t, 7.2 Hz, 1H, arom), 7.84--8.10 (m, 6H, arom), 8.14 (d, *J* = 7.5 Hz, 1H, arom); ^13^C NMR (125 MHz, DMSO-*d*~6~) δ 21.2 (CH~3~), (C-*spiro* and C~quinoxaline~=(CO)~2~): 95.3, 108.9, aromatic carbons: 124.2, 125.9, 126.3, 126.5, 127.1, 131.0, 132.6, 133.4, 133.5, 133.8, 135.4, 135.9, 136.4, 138.4, 138.5, 141.9, (C~qunoxaline~--*N*) and carbonyl carbons: 167.1, 167.7, 177.2, 178.3, 190.0; HRMS (ESI) calcd for C~27~H~18~NO~5~ \[M + H\]^+^: 436.1179; found: 436.1177.

### 1-(Naphthalen-1-ylmethyl)-3′*H*-spiro\[benzo\[*f*\]indole-2,1′-isobenzofuran\]-3,3′,4,9(1*H*)-tetraone (**4e**) {#sec4.4.18}

Red powder; mp 186--188 °C; IR (KBr): 1791.5, 1725.8, 1679.1, 1638.2, 1591.0, 1520.9 cm^--1^; ^1^H NMR (400 MHz, CDCl~3~) δ 5.31 (d, *J* = 15.2 Hz, 1H, H-CHN), 6.26 (d, *J* = 15.2 Hz, 1H, H-CHN), 6.78 (d, *J* = 7.6 Hz, 1H, arom), 7.07 (dt, *J*~1~ = 7.4 Hz, *J*~2~ = 1.2 Hz, 1H, arom), 7.19--7.26 (m, 2H, arom), 7.30--7.32 (m overlapped with the CHCl~3~ peak, 1H, arom), 7.45--7.52 (m, 2H, arom), 7.54--7.59 (m, 2H, arom), 7.70 (dd, *J*~1~ = 8.4 Hz, *J*~2~ = 1.6 Hz, 1H, arom), 7.84 (dt, *J*~1~ = 7.6 Hz, *J*~2~ = 2.8 Hz, 1H, arom), 7.90 (d, *J* = 8.0 Hz, 1H, arom), 7.95 (dt, *J*~1~ = 7.4 Hz, *J*~2~ = 1.2 Hz, 1H, arom), 8.25 (dd, *J*~1~ = 7.8 Hz, *J*~2~ = 1.6 Hz, 1H, arom), 8.33 (dd, *J*~1~ = 7.8 Hz, *J*~2~ = 1.6 Hz, 1H, arom); ^13^C NMR (100 MHz, CDCl~3~) δ 47.3 (CH~2~), (C-*spiro* and C~quinoxaline~=(CO)~2~): 95.2, 109.1, aromatic carbons: 123.4, 123.7, 124.6, 125.5, 125.8, 126.0, 126.3, 127.3, 128.7, 128.9, 129.2, 129.5, 130.8, 132.0, 133.4, 133.6, 135.5, 135.7, 136.0, 137.3, 141.7, (one aromatic carbon, (C~qunoxaline~--*N*) and carbonyl carbons): 167.6, 168.6, 176.8, 180.2, 190.1, 194.9; HRMS (ESI) calcd for C~30~H~18~NO~5~ \[M + H\]^+^: 472.1179; found: 472.1179.

### 1-(3-Methoxyphenyl)-3′*H*-spiro\[benzo\[*f*\]indole-2,1′-isobenzofuran\]-3,3′,4,9(1*H*)-tetraone (**4f**) {#sec4.4.19}

Red powder; mp 198--200 °C; IR (KBr): 1796.3, 1727.6, 1683.3, 1633.2, 1588.4, 1528.4 cm^--1^; ^1^H NMR (400 MHz, DMSO-*d*~6~) δ 3.65 (s, 3H, OMe), 6.65--7.10 (2 × broad peak+ 2 × d, 3H, aromatic protons of the amine moiety), 7.13--7.32 (broad peak, 1H, the aromatic proton of the amine moiety), 7.73 (dt, *J*~1~ = 7.6 Hz, *J*~2~ = 0.8 Hz, 1H, arom), 7.84--7.95 (m, 3H, arom), 7.96--8.07 (m, 3H, arom), 8.15 (dd, *J*~1~ = 7.6 Hz, *J*~2~ = 0.8 Hz, 1H, arom); ^13^C NMR (100 MHz, DMSO-*d*~6~) δ 55.8 (OCH~3~), (C-*spiro*): 95.3, 109.0, (C~quinoxaline~=(CO)~2~) and aromatic carbons: 114.6, 114.8, 120.2, 124.2, 125.9, 126.3, 126.5, 127.1, 128.8, 130.2, 131.3, 132.7, 133.3, 133.4, 134.0, 136.0, 136.5, 141.9, 159.6, (C~qunoxaline~--*N*) and carbonyl carbons: 167.1, 167.8, 177.3, 178.2, 189.9; HRMS (ESI) calcd for C~26~H~16~NO~6~ \[M + H\]^+^: 438.0972; found: 438.0969.

### 1-(3,4,5-Trimethoxyphenyl)-3′*H*-spiro\[benzo\[*f*\]indole-2,1′-isobenzofuran\]-3,3′,4,9(1*H*)-tetraone (**4g**) {#sec4.4.20}

Red powder; mp 188--190 °C; IR (KBr): 1777.9, 1727.8, 1690.8, 1648.8, 1593.4 cm^--1^; ^1^H NMR (400 MHz, DMSO-*d*~6~) δ 3.40--4.00 (broad peak+s, 9H, 3 × OMe overlapped with HOD peak), 6.45--7.80 (broad peak, 2H, aromatic protons of the amine moiety), 7.75 (dt, *J*~1~ = 7.6 Hz, *J*~2~ = 0.8 Hz, 1H, arom), 7.88--7.96 (m, 3H, arom), 7.99 (dt, *J*~1~ = 7.6 Hz, *J*~2~ = 1.2 Hz, 1H, arom), 8.02--8.08 (m, 2H, arom), 8.16 (dd, *J*~1~ = 7.6 Hz, *J*~2~ = 1.2 Hz, 1H, arom); ^13^C NMR (100 MHz, DMSO-*d*~6~) δ 56.4 (OCH~3~), 60.6 (OCH~3~), (C-*spiro*): 95.3, (C~quinoxaline~=(CO)~2~) and aromatic carbons: 106.0, 109.1, 124.2, 125.9, 126.3, 126.5, 127.2, 131.0, 132.7, 133.3, 133.4, 134.0, 135.9, 136.4, 138.0, 142.0, 153.0, (C~qunoxaline~--*N*) and carbonyl carbons: 167.0, 167.8, 177.2, 178.1, 189.8; HRMS (ESI) calcd for C~28~H~20~NO~8~ \[M + H\]^+^: 498.1183; found: 498.1198.

### 1-(3,4-Dimethylphenyl)-3′*H*-spiro\[benzo\[*f*\]indole-2,1′-isobenzofuran\]-3,3′,4,9(1*H*)-tetraone (**4h**) {#sec4.4.21}

Orange powder; mp \> 240 °C; IR (KBr): 1780.8, 1731.9, 1686.1, 1645.2, 1591.6 cm^--1^; ^1^H NMR (400 MHz, DMSO-*d*~6~) δ 2.00--2.15 (broad peak, 3H, Me), 2.17 (s, 3H, Me), 6.80--7.30 (broad peak, 3H, aromatic protons of the amine moiety), 7.73 (t, *J* = 7.6 Hz, 1H, arom), 7.85--8.01 (m, 4H, arom), 8.05 (d, *J* = 8.4 Hz, 1H, arom), 8.16 (d, *J* = 7.2 Hz, 1H, arom); ^13^C NMR (100 MHz, DMSO-*d*~6~) δ 19.5 (CH~3~), 19.8 (CH~3~), (C-*spiro* and C~quinoxaline~=(CO)~2~): 95.3, 108.8, aromatic carbons: 124.2, 125.7, 126.0, 126.3, 126.5, 127.0, 129.1, 130.3, 132.6, 133.1, 133.4, 133.5, 133.8, 135.9, 136.4, 137.4, 137.9, 142.0, (C~qunoxaline~--*N*) and carbonyl carbons: 167.0, 167.8, 177.2, 178.3, 190.0; HRMS (ESI) calcd for C~27~H~18~NO~5~ \[M + H\]^+^: 436.1179; found: 436.1169.

### 1-Benzyl-3′*H*-spiro\[benzo\[*f*\]indole-2,1′-isobenzofuran\]-3,3′,4,9(1*H*)-tetraone (**4i**) {#sec4.4.22}

Orange powder; mp \> 240 °C; IR (KBr): 1798.8, 1718.8, 1684.1, 1642.0, 1591.1 cm^--1^; ^1^H NMR (400 MHz, DMSO-*d*~6~) δ 4.85 (d, *J* = 16.0 Hz, 1H, H-CH-N), 5.17 (d, *J* = 16.0 Hz, 1H, H-CH-N), 7.15--7.25 (broad peak, 5H, arom), 7.65--7.75 (m, 3H, arom), 7.78--7.95 (m, 1H, arom), 7.96--8.05 (m, 2H, arom), 8.15 (t, *J* = 7.6 Hz, 2H, arom); ^13^C NMR (100 MHz, DMSO-*d*~6~) δ 48.4 (CH~2~), (C-*spiro* and C~quinoxaline~=(CO)~2~): 95.1, 108.5, aromatic carbons: 124.0, 126.2, 126.3, 126.4, 127.2, 127.8, 128.0, 128.5, 132.4, 133.5, 133.6, 133.7, 136.0, 136.1, 136.2, 141.9, (C~qunoxaline~--*N*) and carbonyl carbons: 167.7, 167.9, 176.8, 180.0, 189.9; HRMS (ESI) calcd for C~26~H~16~NO~5~ \[M + H\]^+^: 422.1023; found: 422.1021.

### 1-(2-Chlorobenzyl)-3′*H*-spiro\[benzo\[*f*\]indole-2,1′-isobenzofuran\]-3,3′,4,9(1*H*)-tetraone (**4j**) {#sec4.4.23}

Orange powder; mp 217--219 °C; IR (KBr): 1782.0, 1725.1, 1680.3, 1643.3, 1588.9 cm^--1^; ^1^H NMR (400 MHz, DMSO-*d*~6~) δ 4.85 (d, *J* = 16.4 Hz, 1H, H-CH-N), 5.34 (d, *J* = 16.4 Hz, 1H, H-CH-N), 7.22--7.31 (broad peak, 2H, arom), 7.51--7.54 (m, 1H, arom), 7.70--7.79 (m, 3H, arom), 7.83--8.03 (m, 4H, arom), 8.14 (dd, *J*~1~ = 8.8 Hz, *J*~2~ = 0.8 Hz, 2H, arom); ^13^C NMR (100 MHz, DMSO-*d*~6~) δ 45.8 (CH~2~), (C-*spiro* and C~quinoxaline~=(CO)~2~): 95.1, 108.8, aromatic carbons: 123.8, 126.2, 126.3, 126.4, 127.3, 127.6, 129.4, 129.7, 129.8, 132.0, 132.5, 133.4, 133.5, 133.6, 133.8, 136.1, 141.4, (C~qunoxaline~--*N*) and carbonyl carbons: 167.6, 168.1, 176.8, 179.9, 189.8; HRMS (ESI) calcd for C~26~H~15~ClNO~5~ \[M + H\]^+^: 456.0633; found: 456.0632.

### 1-(Furan-3-ylmethyl)-3′*H*-spiro\[benzo\[*f*\]indole-2,1′-isobenzofuran\]-3,3′,4,9(1*H*)-tetraone (**4k**) {#sec4.4.24}

Orange powder; mp 208--210 °C; IR (KBr): 1798.2, 1738.0, 1715.6, 1698.8, 1686.4, 1651.4, 1589.1, 1527.7 cm^--1^; ^1^H NMR (300 MHz, DMSO-*d*~6~) δ 5.04 (d, *J* = 15.9 Hz, 1H, H-CH-N), 6.13 (d, *J* = 15.9 Hz, 1H, H-CH-N), 6.14 (d, *J* = 2.7 Hz, 1H, arom), 6.23 (dd, *J*~1~ = 3.2 Hz, *J*~2~ = 1.8 Hz, 1H arom), 7.39 (s, 1H, arom), 7.60--7.67 (m, 1H, arom), 7.72--8.82 (m, 2H, arom), 7.89--8.01 (m, 3H, arom), 8.12 (d, *J* = 6.6 Hz, 1H, arom), 8.19 (d, *J* = 7.2 Hz, 1H, arom); ^13^C NMR (75 MHz, DMSO-*d*~6~) δ 21.5 (CH~2~), (C-*spiro* and C~quinoxaline~=(CO)~2~): 94.5, 108.5, aromatic carbons: 110.0, 111.1, 123.5, 126.1, 126.2, 126.4, 126.8, 127.3, 132.3, 133.4, 133.5, 133.8, 136.1, 141.9, 143.3, 148.6, (C~qunoxaline~--*N*) and carbonyl carbons: 167.4, 167.7, 176.7, 180.0, 189.9; HRMS (ESI) calcd for C~24~H~14~NO~6~ \[M + H\]^+^: 412.0816; found: 412.0811.

### 1-Phenethyl-3′*H*-spiro\[benzo\[*f*\]indole-2,1′-isobenzofuran\]-3,3′,4,9(1*H*)-tetraone (**4l**) {#sec4.4.25}

Orange powder; mp 232--234 °C; IR (KBr): 1796.4, 1754.9, 1693.5, 1609.2, 1580.6, 1534.4 cm^--1^; ^1^H NMR (300 MHz, DMSO-*d*~6~) δ 2.70--2.93 (m, 1H, H-CHPh), 2.90--3.10 (m, 1H, H-CHPh), 3.56--3.63 (m, 1H, H-CH-N), 3.95--4.11 (m, 1H, H-CH-N), 7.11--7.33 (m, 5H, arom), 7.81--8.03 (m, 5H, arom), 8.13 (d, *J* = 7.5 Hz, 2H, arom), 8.20 (d, *J* = 6.9 Hz, 1H, arom); ^13^C NMR (75 MHz, DMSO-*d*~6~) δ 36.1 (CH~2~), 46.5 (CH~2~), (C-*spiro* and C~quinoxaline~=(CO)~2~): 95.1, 107.9, aromatic carbons: 123.9, 126.4, 126.6, 127.0, 127.2, 129.0, 129.1, 132.7, 133.4, 133.7, 135.9, 136.4, 138.1, 141.9, (C~qunoxaline~--*N*) and carbonyl carbons: 167.7, 167.8, 176.5, 179.8, 189.6; HRMS (ESI) calcd for C~27~H~18~NO~5~ \[M + H\]^+^: 436.1179; found: 436.1180.

### 1-Ethyl-3′*H*-spiro\[benzo\[*f*\]indole-2,1′-isobenzofuran\]-3,3′,4,9(1*H*)-tetraone (**4m**) {#sec4.4.26}

Red powder; mp \> 240 °C; IR (KBr): 1780.0, 1730.8, 1701.6, 1683.3, 1654.3, 1590.6 cm^--1^; ^1^H NMR (300 MHz, DMSO-*d*~6~) δ 1.12 (t, *J* = 7.2 Hz, 3H, CH~3~), 3.51 (dt, *J*~1~ = 14.0 Hz, *J*~2~ = 6.9 Hz, 1H, H-CHMe), 3.86 (dt, *J*~1~ = 14.0 Hz, *J*~2~ = 6.9 Hz, 1H, H-CHMe), 7.80--8.10 (m, 5H, arom), 8.12 (d, *J* = 7.2 Hz, 2H, arom), 8.17 (d, *J* = 7.2 Hz, 1H, arom); ^13^C NMR (75 MHz, DMSO-*d*~6~) δ 15.5 (CH~3~), 31.2 (CH~2~), (C-*spiro* and C~quinoxaline~=(CO)~2~): 95.1, 107.7, aromatic carbons: 123.9, 126.3, 126.4, 126.5, 127.1, 132.7, 133.4, 133.6, 133.7, 135.9, 136.4, 142.1, (C~qunoxaline~--*N*) and carbonyl carbons: 167.7, 167.9, 176.4, 179.7, 189.6; HRMS (ESI) calcd for C~21~H~14~NO~5~ \[M + H\]^+^: 360.0866; found: 360.0863.

### 3-(3-Ethoxyphenyl)-3′*H*-spiro\[benzo\[*a*\]pyrrolo\[2,3-*c*\]phenazine-2,1′-isobenzofuran\]-1,3′(3*H*)-dione (**6a**) {#sec4.4.27}

Both ^1^H and ^13^C NMR spectra of this compound clearly show a 1:1 mixture of two rotamers. Yellow solid; mp \> 250 °C; IR (KBr): 1779.3, 1711.8, 1602.7, 1578.9, 1556.6 cm^--1^; ^1^H NMR (400 MHz, DMSO-*d*~6~) δ 1.16 (t, *J* = 9.2 Hz, 3H, CH~3~), 1.30 (t, *J* = 9.2 Hz, 3H, CH~3~), 3.74--3.88 (m, 2H, CH~2~), 3.90--4.10 (m, 2H, CH~2~), 6.81--7.11 (m, 6H, arom), 7.26 (t, *J* = 8.1 Hz, 1H, arom), 7.33--7.46(m, 3H, arom), 7.58--7.85 (m, 6H, arom), 7.88--8.11 (m, 10H, arom), 8.15--8.35 (m, 4H, arom), 9.37 (d, *J* = 10.8, 2H, arom); ^13^C NMR (100 MHz, DMSO-*d*~6~) δ 14.7 (CH~3~), 14.8 (CH~3~), 63.8 (CH~2~), 63.9 (CH~2~), (C-spiro and C~quinoxaline~=(CO)~2~): 96.4, 96.5, 107.4, 107.5, aromatic carbons and carbonyl carbons: 114.4, 115.0, 115.1, 115.8, 116.5, 117.7, 120.3, 121.1, 123.6, 124.5, 124.6, 125.9, 126.8, 126.9, 127.0, 127.3, 128.9, 129.9, 130.0, 130.3, 130.9, 131.4, 131.6, 132.1, 133.4, 135.4, 135.8, 135.9, 136.0, 139.1, 140.1, 140.2, 140.7, 142.6, 142.7, 143.2, (C-OEt, C~quinoxaline~--*N* and carbonyl carbons): 159.5, 159.9, 167.5, 167.6, 168.2, 168.2, 188.7, 188.8; HRMS (ESI) calcd for C~33~H~22~N~3~O~4~ \[M + H\]^+^: 524.1610; found: 524.1601.

### 3-(3-Methoxyphenyl)-3′*H*-spiro\[benzo\[*a*\]pyrrolo\[2,3-*c*\]phenazine-2,1′-isobenzofuran\]-1,3′(3*H*)-dione (**6b**) {#sec4.4.28}

Both ^1^H and ^13^C NMR spectra of this compound clearly show a 1:1 mixture of two rotamers. Yellow powder; mp \> 240 °C; IR (KBr): 1779.4, 1710.8, 1601.5, 1579.2, 1533.0 cm^--1^; ^1^H NMR (300 MHz, DMSO-*d*~6~) δ 3.56 (s, 3H, OCH~3~), 3.73 (s, 3H, OCH~3~), 6.84--7.08(m, 6H, arom), 7.24--7.42 (m, 4H, arom), 7.60--7.84 (m, 6H, arom), 7.88--8.10 (m, 10H, arom), 8.20 (d, *J* = 8.3 Hz, 2H, arom), 8.30 (d, *J* = 8.3 Hz, 2H, arom), 9.28--9.49 (m, 2H, arom); ^13^C NMR (75 MHz, DMSO-*d*~6~) δ 55.8 (OCH~3~), 55.9 (OCH~3~), (C-*spiro* and C~quinoxaline~=(CO)~2~): 96.5, 107.4, 107.5, aromatic carbons: 114.1, 115.0, 115.1, 115.5, 120.4, 121.2, 123.7, 124.5, 124.6, 125.9, 126.8, 126.9, 127.0, 127.1, 127.2, 127.3, 128.9, 129.9, 130.0, 130.3, 130.4, 131.0, 131.5, 131.7, 132.1, 133.4, 135.7, 135.8, 135.9, 136.0, 139.0, 139.1, 140.0, 140.1, 140.2, 140.7, 142.6, 142.7, 143.2, (C-OMe, C~quinoxaline~--*N* and carbonyl carbons): 160.3, 160.6, 167.5, 167.6, 168.1, 168.2, 172.5, 188.7, 188.8. HRMS (ESI) calcd for C~32~H~20~N~3~O~4~ \[M + H\]^+^: 510.1448; found: 510.1455.

### 3-(3,5-Dimethylphenyl)-3′*H*-spiro\[benzo\[*a*\]pyrrolo\[2,3-*c*\]phenazine-2,1′-isobenzofuran\]-1,3′(3*H*)-dione (**6c**) {#sec4.4.29}

Yellow solid; mp \> 250 °C; IR (KBr): 1788.3, 1718.6, 1692.0, 1598.7, 1571.8, 1538.6 cm^--1^; ^1^H NMR (300 MHz, DMSO-*d*~6~) δ 2.10 (s, 3H, CH~3~), 2.25 (s, 3H, CH~3~), 6.93 (s, 1H, arom), 7.05 (s, 1H, arom), 7.10 (s, 1H, arom), 7.08 (d, *J* = 8.4 Hz, 1H, arom), 7.62 (t, *J* = 8.4 Hz, 1H, arom), 7.7 (t, *J* = 7.5 Hz, 1H, arom), 7.82 (t, *J* = 8.1 Hz, 1H, arom), 7.89--8.04 (m, 5H, arom), 8.18 (dt, *J*~1~ = 7.8, *J*~2~ = 1.2 Hz, 1H, arom), 8.27 (dt, *J*~1~ = 8.5, *J*~2~ = 1.5 Hz, 1H, arom), 9.35 (d, *J* = 8.1 Hz, 1H, arom); ^13^C NMR (75 MHz, DMSO-*d*~6~) δ 21.1 (CH~3~), 21.2 (CH~3~), (C-*spiro* and C~quinoxaline~=(CO)~2~): 96.4, 107.2, aromatic carbons: 123.7, 124.5, 125.9, 126.0, 126.7, 126.9, 127.1, 127.3, 128.9, 130.0, 130.3, 131.3, 131.6, 132.1, 133.5, 135.9, 136.0, 137.8, 139.5, 140.0, 140.1, 140.2, 140.7, 142.7, 143.2, (C~quinoxaline~--*N* and carbonyl carbons): 167.6, 168.2, 172.5, 188.9; HRMS (ESI) calcd for C~33~H~22~N~3~O~3~ \[M + H\]^+^: 508.1656; found: 508.1630.

### 3-(3,4-Dimethylphenyl)-3′*H*-spiro\[benzo\[*a*\]pyrrolo\[2,3-*c*\]phenazine-2,1′-isobenzofuran\]-1,3′(3*H*)-dione (**6d**) {#sec4.4.30}

Both ^1^H and ^13^C NMR spectra of this compound clearly show a 1:1 mixture of two rotamers. Yellow solid; mp \> 250 °C; IR (KBr): 1790.6, 1714.1, 1691.3, 1603.6, 1520.4 cm^--1^; ^1^H NMR (400 MHz, DMSO-*d*~6~) δ 2.06 (s, 3H, CH~3~), 2.21 (s, 9H, CH~3~), 7.04 (dd, *J*~1~ = 8.0 Hz, *J*~2~ = 1.6 Hz, 1H, arom), 7.10--7.15 (m, 2H, arom), 7.22 (dd, *J*~1~ = 8.0 Hz, *J*~2~ = 1.6 Hz, 1H, arom), 7.25--7.28 (m, 1H, arom), 7.29--7.36 (m, 3H, arom), 7.62--7.74 (m, 4H, arom), 7.79--7.86 (m, 2H, arom), 7.89--7.96 (m, 5H, arom), 8.96--8.02 (m, 3H, arom), 8.03--8.08(m, 2H, arom), 8.18--8.23 (m, 2H, arom), 8.28--8.35 (m, 2H, arom), 9.37--9.45 (m, 2H, arom); ^13^C NMR (100 MHz, DMSO-*d*~6~) δ 19.5 (CH~3~), 19.7 (CH~3~), 19.8 (CH~3~), 21.5 (CH~3~), (C-*spiro* and C~quinoxaline~=(CO)~2~): 96.4, 96.5, 106.9, 107.0, aromatic carbons: 123.6, 123.7, 124.5, 125.8, 125.9, 126.0, 126.6, 126.9, 127.0, 127.1, 127.2, 128.9, 129.4, 129.8, 129.9, 130.0, 130.3, 131.1, 131.5, 131.6, 132.1, 133.3, 133.4, 135.3, 135.4, 135.8, 135.9, 136.0, 138.2, 138.3, 138.5, 139.0, 140.1, 140.2, 140.8, 140.9, 142.7, 142.8, 143.2, (C~quinoxaline~--*N* and carbonyl carbons): 167.5, 167.6, 168.2, 172.5, 188.8, 188.9; HRMS (ESI) calcd for C~33~H~22~N~3~O~3~ \[M + H\]^+^: 508.1656; found: 508.1586.

### 3-(3,5-Dimethylphenyl)-10(11)-methyl-3′*H*-spiro\[benzo\[*a*\]pyrrolo\[2,3-*c*\]phenazine-2,1′-isobenzofuran\]-1,3′(3*H*)-dione (**6e**) {#sec4.4.31}

Both H and C NMR spectra shown a mixture of two structural isomers based on whether Me is attached on C-10 or C-11, with a ratio of almost 1:1. Yellow solid; mp \> 250 °C; IR (KBr): 1800.0, 1709.0, 1603.0, 1577.6, 1558.8, 1537.4, 1522.1, 1504.7 cm^--1^; ^1^H NMR (500 MHz, DMSO-*d*~6~) δ 2.09 (s, 6H, CH~3~), 2.24 (s, 6H, CH~3~), 2.62 (s, 3H, CH~3~), 2.63 (s, 3H, CH~3~), 6.91 (s, 2H, arom), 7.04 (s, 2H, arom), 7.08 (s, 2H, arom), 7.31 (dd, *J*~1~ = 8.5 Hz, *J*~2~ = 4.1, 2H, arom), 7.59 (d, *J* = 6.9 Hz, 1H, arom), 7.62 (d, *J* = 7.1 Hz, 1H, arom), 7.66--7.82 (m, 6H, arom), 7.91--8.08 (m, 9H, arom), 8.15 (d, *J* = 8.7 Hz, 1H, arom), 9.30--9.37 (m, 2H, arom); ^13^C NMR (125 MHz, DMSO-*d*~6~) δ 21.1 (CH~3~), 21.2 (CH~3~), 21.9 (CH~3~), 22.0 (CH~3~), (C-*spiro* and C~quinoxaline~=(CO)~2~): 96.4, 96.5, 107.3, 107.4, aromatic carbons: 123.4, 123.5, 124.4, 124.5, 125.8, 125.9, 126.0, 126.5, 126.6, 126.7, 126.8, 126.9, 127.0, 127.2, 127.4, 128.4, 128.5, 129.5, 130.0, 130.1, 131.1, 132.2, 132.1, 132.4, 133.2, 133.3, 134.1, 135.8, 136.0, 136.1, 137.9, 138.0, 138.8, 139.2, 139.4, 139.8, 140.0, 140.2, 140.3, 140.6, 141.8, 142.1, 142.7, 143.3, (C~quinoxaline~--*N* and carbonyl carbons): 167.2, 167.3, 168.1, 168.2, 188.8, 188.9; HRMS (ESI) calcd for C~34~H~24~N~3~O~3~ \[M + H\]^+^: 522.1812; found: 522.1775.

### 3-(3,4-Dimethylphenyl)-10(11)-nitro-3′*H*-spiro\[benzo\[*a*\]pyrrolo\[2,3-*c*\]phenazine-2,1′-isobenzofuran\]-1,3′(3*H*)-dione (**6f**) {#sec4.4.32}

Yellow solid; mp \> 250 °C; IR (KBr): 1786.7, 1717.8, 1637.0, 1606.5, 1581.2, 1557.1, 1533.0 cm^--1^; ^1^H NMR (500 MHz, DMSO-*d*~6~) (the ^1^H NMR spectrum of the product shows a mixture of two structural isomer based on whether NO~2~ is attached on C-10 or C-11, with a ratio of about 1:0.4) δ 2.10 (two overlapped s, 4.32H, CH~3~ of both isomers), 2.27 (two overlapped s, 1.32H, CH~3~ of both isomers), 6.89 and 6.91 (two overlapped s, 1.44H, arom), 7.04--7.16 (four overlapped s, 2.88H, arom), 7.29 (two overlapped d, *J*^(for the major isomer)^ = 8.4 Hz, 1.46H, arom), 7.65--7.75 (m, 2.88H, arom), 7.82 (two overlapped t, *J*^(for the major isomer)^ = 7.6 Hz, 1.44H, arom), 7.94 (two overlapped d, *J*^(for the major isomer)^ = 7.6 Hz, 1.44H, arom), 8.00 (two overlapped d, *J*^(for the major isomer)^ = 7.5 Hz, 1.45H, arom), 8.03--8.09 (m, 1.46H, arom), 8.29 (d, *J* = 9.2 Hz, 0.34H, arom), 8.41 (d, *J* = 9.2 Hz, 1H, arom), 8.51 (d, *J* = 9.3Hz, 1H, arom), 8.55 (d, *J* = 9.6Hz, 1H, arom), 8.82 (s, 1H, arom), 8.97 (s, 0.28H, arom), 9.37 (two overlapped d, *J* = 7.8 Hz, 1.38H, arom); the solubility of the compound is too low to record a suitable ^13^CNMR spectrum; however, the spectrum was recorded at 80 °C using overnight pulsing, which clearly showed the existence of two structures. ^13^C NMR (125 MHz, DMSO-*d*~6~) δ 20.9 (CH~3~), 21.1 (CH~3~), (C-*spiro* and C~quinoxaline~=(CO)~2~): 96.4, 106.7, aromatic carbons: 122.4, 124.1, 124.2, 124.3, 124.4, 124.7, 125.8, 126.0, 126.2, 126.5, 127.0, 127.5, 127.8, 130.6, 131.1, 131.3, 131.4, 131.5, 131.8, 132.1, 132.2, 133.7, 133.8, 135.4, 135.5, 135.7, 137.3, 137.4, 138.5, 139.6, 139.7, 140.1, 140.2, 141.8, 142.3, 142.5, 142.6, 142.7, 143.0, 145.6, 145.6, 147.2, 148.6, (C~quinoxaline~--*N* and carbonyl carbons): 167.8, 168.0, 168.4, 188.3, 188.4; MS (EI): *m*/*z* (%): 552 (\[M\]^+^, 40%), 303 (100), 282 (72); HRMS (ESI) calcd for C~33~H~21~N~4~O~5~ \[M + H\]^+^: 553.1506; found: 553.1520.

### 3-(3-Methoxyphenyl)-10(11)-nitro-3′*H*-spiro\[benzo\[*a*\]pyrrolo\[2,3-*c*\]phenazine-2,1′-isobenzofuran\]-1,3′(3*H*)-dione (**6g**) {#sec4.4.33}

Both ^1^H and ^13^C NMR spectra of this compound show a mixture of some rotamers and or structural isomers based on the position of NO~2~ as well as OMe substituents. Because of highly overlapping signals, their composition ratio was not calculated. Yellow solid; mp \> 250 °C; IR (KBr): 1878.8, 1710.2, 1621.4, 1578.5, 1520.0, cm^--1^; ^1^H NMR (400 MHz, DMSO-*d*~6~) δ 3.53 (s, 5.76H, OCH~3~), 3.74 (s, 5.77H, OCH~3~), 6.81--7.12 (m, 5.91H, arom), 7.27 (t, *J* = 8.2 Hz, 1H, arom), 7.36 (d, *J* = 8.3 Hz, 1.72H, arom), 7.42 (t, *J* = 8.3 Hz, 1H, arom), 7.63--7.76 (m, 6.33H, arom), 7.88--8.11 (m, 6H, arom), 8.30 (d, *J* = 9.3 Hz, 0.26H, arom), 8.38--8.63 (m, 3.62H, arom), 8.80--8.87 (m, 1.24H, arom), 8.96--9.00 (m, 0.17H, arom), 9.27--9.37 (m, 1.5H, arom); ^13^C NMR (125 MHz, DMSO-*d*~6~) δ 55.8 (OCH~3~), 55.9 (OCH~3~), (C-*spiro* and C~quinoxaline~=(CO)~2~): 96.4, 106.6, 106.7, aromatic carbons: 114.3, 115.0, 115.4, 115.8, 117.0, 119.3, 120.5, 121.2, 122.6, 123.9, 124.2, 124.3, 124.4, 124.6, 124.7, 126.0, 126.1, 126.7, 126.8, 127.4, 127.5, 130.6, 127.7, 130.6, 131.1, 131.4, 131.5, 131.6, 131.8, 132.3, 133.8, 134.4, 135.2, 135.3, 135.9, 136.0, 138.5, 138.6, 141.6, 142.2, 142.3, 142.4, 142.5, 142.6, 142.7, 148.4, 151.6, (C-OMe, C~quinoxaline~--*N* and carbonyl carbons): 160.4, 160.7, 168.0, 168.1, 168.2, 168.3, 172.4, 188.4, 188.5; HRMS (ESI) calcd for C~32~H~19~N~4~O~6~ \[M + H\]^+^: 555.1299; found: 555.1313.

### 3-(3-Methoxyphenyl)-1,3′-dioxo-1,3-dihydro-3′*H*-spiro\[benzo\[*a*\]pyrrolo\[2,3-*c*\]phenazine-2,1′-isobenzofuran\]-10(11)-carboxylic acid (**6h**) {#sec4.4.34}

Both ^1^H and ^13^C NMR spectra of this compound show a 1:0.9 mixture of two rotamers. Yellow solid; mp \> 250 °C; IR (KBr): 3094.4-3450.9 (bp, CO~2~H), 1794.3, 1753.9, 1724.1, 1697.6, 1602.3, 1581.3 cm^--1^; ^1^H NMR (400 MHz, DMSO-*d*~6~) δ 3.57 (s, 3H, OCH~3~), 3.73 (s, 2.7H, OCH~3~), 6.90 (dt, *J*~1~ = 8.0 Hz, *J*~2~ = 0.8 Hz, 0.9H, arom), 6.96 (dd, *J*~1~ = 4.4 Hz, *J*~2~ = 2.0 Hz, 0.9H, arom), 7.00 (dt, *J*~1~ = 8.4 Hz, *J*~2~ = 1.2 Hz, 1.9H, arom), 7.05--7.10 (m, 2H, arom), 7.29 (t, *J* = 8.0 Hz, 1H, arom), 7.39--7.46 (m, 2.9H, arom), 7.67--7.76 (m, 3.9H, arom), 7.79--7.86 (m, 2H, arom), 7.93--8.00 (m, 2.9H, arom), 8.03 (d, *J* = 8.0 Hz, 1H, arom), 8.08--8.14 (m, 2H, arom), 8.27 (d, *J* = 8.8 Hz, 0.9H, arom), 8.33--8.42 (m, 3H, arom), 8.70--8.72 (bp, 1H, arom), 8.84 (d, *J* = 1.6 Hz, 0.9H, arom), 9.40--9.46 (m, 1.9H, arom); ^13^C NMR (100 MHz, DMSO-*d*~6~) δ 55.8 (OCH~3~), 55.9 (OCH~3~), (C-*spiro* and C~quinoxaline~=(CO)~2~): 96.5, 107.2, 107.3, aromatic carbons: 114.2, 115.0, 115.2, 120.5, 121.2, 123.8, 124.0, 124.5, 124.6, 126.0, 126.8, 126.9, 127.4, 127.5, 129.3, 130.0, 130.4, 130.9, 131.0, 131.5, 132.2, 133.7, 135.9, 136.0, 138.9, 139.0, 141.5, 141.6, 141.8, 142.4, 142.5, 142.6, (C-OMe, C~quinoxaline~--*N* and carbonyl carbons): 160.3, 160.7, 167.8, 167.9, 168.1, 168.2, 188.7, 188.8; HRMS (ESI) calcd for C~33~H~19~N~3~O~6~ \[M + H\]^+^: 554.1347; found: 553.1296.

### 3-(3,5-Dimethylphenyl)-3′*H*-spiro\[dibenzo\[*a,i*\]pyrrolo\[2,3-*c*\]phenazine-2,1′-isobenzofuran\]-1,3′(3*H*)-dione (**6i**) {#sec4.4.35}

Yellow solid; mp \> 250 °C; IR (KBr): 1787.6, 1713.9, 1622.0, 1603.6, 1579.9, 1519.3 cm^--1^; ^1^H NMR (400 MHz, DMSO-d6) δ 2.11 (s, 3H, CH~3~), 2.28 (s, 3H, CH~3~), 6.92 (s, 1H, arom), 7.06 (s, 1H, arom), 7.11 (s, 1H, arom), 7.25 (d, *J* = 10.8 Hz, 1H, arom), 7.55--7.68 (m, 3H, arom), 7.72 (t, *J* = 10.0 Hz, 1H, arom), 7.83 (dt, *J*~1~ = 10.0 Hz, *J*~2~ = 1.2 Hz, 1H, arom), 7.93--8.08 (m, 3H, arom), 8.28 (dd, *J*~1~ = 9.8 Hz, *J*~2~ = 5.6 Hz, 2H, arom), 8.84 (s, 1H, arom), 8.93 (s, 1H, arom), 9.36 (d, *J* = 10.4 Hz, 1H, arom); ^13^C NMR (100 MHz, DMSO-*d*~6~) δ 21.1 (CH~3~), 21.2 (CH~3~), (C-*spiro* and C~quinoxaline~=(CO)~2~): 96.4, 107.1, aromatic carbons: 123.9, 124.5, 125.9, 126.0, 126.5, 126.6, 126.9, 127.3, 127.4, 127.5, 128.2, 128.7, 128.8, 130.6, 131.3, 132.2, 133.4, 133.6, 134.6, 135.8, 135.9, 137.2, 137.7, 139.5, 139.6, 140.0, 141.5, 141.8, 142.8, (C~quinoxaline~--*N* and carbonyl carbons): 168.2, 168.3, 172.5, 188.5; HRMS (ESI) calcd for C~37~H~24~N~3~O~3~ \[M + H\]^+^: 558.1812; found: 558.1836.

### 3-(3,4-Dimethylphenyl)-3′*H*-spiro\[dibenzo\[*a,i*\]pyrrolo\[2,3-*c*\]phenazine-2,1′-isobenzofuran\]-1,3′(3*H*)-dione (**6j**) {#sec4.4.36}

Both ^1^H and ^13^C NMR spectra of this compound clearly show the existence of two rotamers, and the calculation based on the ^1^H NMR spectrum stablished that their ratio is about 0.7:0.5 (3:2.1). Yellow solid; mp \> 250 °C; IR (KBr): 1777.6, 1719.5, 1701.9, 1696.9, 1691.0, 1686.0, 1600.1 cm^--1^; ^1^H NMR (300 MHz, DMSO-*d*~6~) δ 2.06 (s, 2.0H, *meta*-CH~3~ of the minor rotamer), 2.15--2.29 (two overlapped bp, 7.6H, *para*-CH~3~ of two rotamer + *meta*-CH~3~ of the major rotamer), 6.89 (dd, *J*~1~ = 8.0 Hz, *J*~2~ = 2.1 Hz, 0.5H, arom), 6.92--6.99 (m, 0.7H, arom), 7.03 (dd, *J*~1~ = 8.0 Hz, *J*~2~ = 2.1 Hz, 0.5H, arom), 7.09--7.12 (bp, 0.7H, arom), 7.14 (s, 0.5H, arom), 7.20--7.37 (m, 3.7H, arom), 7.54--7.78 (m, 5.8H, arom), 7.79--7.14 (m, 7.4H, arom), 8.20 (dd, *J*~1~ = 7.7 Hz, *J*~2~ = 0.9 Hz, 0.7H, arom), 8.24--8.41 (overlapped m and s, 3.5H, arom), 8.88 (s, 1.2H, arom), 8.99 (s, 1.2H, arom), 9.42 (d, J = 8.1 Hz, 1.2H, arom); ^13^C NMR (75 MHz, DMSO-*d*~6~) δ 19.6 (CH~3~), 19.7 (CH~3~), 19.8 (CH~3~), 19.9 (CH~3~), (C-*spiro* and C~quinoxaline~=(CO)~2~): 96.4, 96.5, 106.9, 109.1, aromatic carbons: 124.0, 124.1, 124.4, 124.5, 125.9, 126.0, 126.1, 126.2, 126.5, 126.8, 126.9, 126.9, 127.0, 127.4, 127.5, 127.6, 128.2, 128.7, 128.8, 129.3, 129.4, 129.8, 130.2, 130.7, 131.1, 131.4, 131.6, 131.8, 132.2, 132.6, 133.2, 133.3, 133.4, 133.7, 134.2, 134.3, 134.6, 134.7, 134.8, 135.2, 135.3, 135.6, 135.9, 136.0, 136.1, 136.3, 136.4, 137.3, 138.3, 138.4, 138.5, 138.9, 139.0, 139.4, 139.6, 141.6, 141.7, 141.9, 142.2, 142.8, 142.9, (C~quinoxaline~--*N* and carbonyl carbons): 168.2, 168.4, 171.2, 174.3, 186.8, 188.6; HRMS (ESI) calcd for C~37~H~24~N~3~O~3~ \[M + H\]^+^: 558.1812; found: 558.1854.

### 1-Phenyl-3′*H*-spiro\[benzo\[*f*\]pyrrolo\[2,3-*h*\]quinoxaline-2,1′-isobenzofuran\]-3,3′(1*H*)-dione (**9a**) {#sec4.4.37}

Yellow solid; mp \> 250 °C; IR (KBr): 1793.6, 1776.0, 1723.1, 1696.6, 1571.3; cm^--1^; ^1^H NMR (300 MHz, DMSO-*d*~6~) δ 7.14--7.54 (m, 6H, arom), 7.56 (t, *J* = 7.8 Hz, 1H, arom), 7.68 (t, *J* = 7.5 Hz, 1H, arom), 7.79 (t, *J* = 7.2 Hz, 1H, arom), 7.87--8.10 (m, 3H, arom), 8.89 (s, 1H, arom),T 8.99 (s, 1H, arom), 9.21 (d, *J* = 7.8 Hz, 1H, arom); ^13^C NMR (75 MHz, DMSO-*d*~6~) δ (C-*spiro* and C~quinoxaline~=(CO)~2~): 96.6, 107.9, aromatic carbons: 122.6, 124.5, 125.9, 126.2, 126.6, 127.0, 128.5, 129.1, 129.4, 129.6, 130.2, 130.7, 132.1, 133.0, 135.9, 136.2, 137.9, 138.3, 139.9, 142.3, 142.5, 146.6, (C~quinoxaline~--*N* and carbonyl carbons): 165.6, 168.2, 189.6; HRMS (ESI) calcd for C~27~H~16~N~3~O~3~ \[M + H\]^+^: 430.1186; found: 430.1187.

### 1-(*o*-Tolyl)-3′*H*-spiro\[benzo\[*f*\]pyrrolo\[2,3-*h*\]quinoxaline-2,1′-isobenzofuran\]-3,3′(1*H*)-dione (**9b**) {#sec4.4.38}

Both ^1^H and ^13^C NMR spectra of this compound show the existence of two rotamers, and the calculation based on the ^1^H NMR spectrum stablished that their ratio is almost 1:0.2. Yellow solid; mp \> 250 °C; IR (KBr): 1792.3, 1699.4, 1603.3, 1580.2, 1558.6, 1537.4 cm^--1^; ^1^H NMR (500 MHz, DMSO-*d*~6~) δ 2.00 (s, 0.6H, CH~3~ of the minor rotamer), 2.21 (s, 3H, CH~3~ of the major rotamer), 7.08 (d, *J* = 8.0 Hz, 1H, arom), 7.11--7.27 (m, 2.2H, arom), 7.28--7.46 (m, 2.6H, arom), 7.57 (two overlapped t, *J* = 8.0 Hz, 1.2H, arom), 7.65--7.84 (m, 1.6H, arom), 7.86--7.96 (m, 2.2H, arom), 8.00 (t, *J* = 7.7 Hz, 1H, arom), 8.08 (d, *J* = 7.8 Hz, 1H, arom), 8.34--8.94 (bp, 1H, arom), 8.95--9.00 (bp, 1H, arom), 9.24 (d, 8.3 Hz, 1H, arom); ^13^C NMR (125 MHz, DMSO-*d*~6~) δ 18.5 (CH~3~), 18.8 (CH~3~), (C-*spiro* and C~quinoxaline~=(CO)~2~): 96.1, 97.0, 106.8, 107.4, aromatic carbons: 123.1, 123.2, 124.6, 124.7, 125.1, 125.2, 125.8, 126.0, 126.3, 126.7, 127.2, 127.8, 128.1, 130.0, 130.1, 130.2, 130.3, 130.5, 132.2, 132.3, 132.4, 133.2, 133.3, 135.8, 136.1, 136.2, 136.3, 136.5, 137.3, 137.7, 137.8, 138.4, 138.7, 140.0, 140.2, 142.2, 142.3, 142.4, 143.0, 146.6, 144.7, (C~quinoxaline~--*N* and carbonyl carbons): 165.8, 165.9, 167.9, 168.0, 189.5, 189.9; HRMS (ESI) calcd for C~28~H~18~N~3~O~3~ \[M + H\]^+^: 444.1343; found: 444.1337.

### 12-(4-Bromophenyl)-6b,11b-dihydroxy-11b,12-dihydrobenzo\[*g*\]indeno\[1,2-*b*\]indole-5,6,7(6b*H*)-trione (Intermediate A for Product **2b**) {#sec4.4.39}

^1^H NMR (300 MHz, DMSO-*d*~6~) δ 5.8--6.7 (broad peak, 1H, OH), 6.73 (dd, *J*~1~ = 8.0 Hz, *J*~2~ = 1.0 Hz, 1H, arom), 6.97 (d, *J* = 7.6 Hz, 1H, arom), 7.03 (dd, *J*~1~ = 8.5 Hz, *J*~2~ = 2.6 Hz, 1H, arom), 7.42 (dt, *J*~1~ = 8.0 Hz, *J*~2~ = 1.5 Hz, 1H, arom), 7.54 (dt, *J*~1~ = 6.0 Hz, *J*~2~ = 1.1 Hz, 1H, arom), 7.58--7.71 (m, 3H, arom), 11.04-12.80 (broad peak, 1H, OH); ^13^C NMR (75 MHz, DMSO-*d*~6~) δ 83.8, 99.1, 112.9, 122.7, 123.9, 126.0, 127.1, 127.5, 129.3, 131.3, 131.8, 132.2, 132.6, 132.8, 133.1, 133.3, 134.0, 135.2, 135.7, 137.5, 147.4, 155.7, 172.4, 172.5, 182.3, 196.7.

### 4b,11b-Dihydroxy-5-(naphthalen-2-ylmethyl)-5,11b-dihydrobenzo\[*f*\]indeno\[1,2-*b*\]indole-6,11,12(4b*H*)-trione (Intermediate A for Product **4e**) {#sec4.4.40}

IR (KBr): 1729.0, 1717.5, 1681.0, 1673.4, 1634.3, 1601.8 cm^--1^; ^1^H NMR (400 MHz, DMSO-*d*~6~) δ 3.34 (s, 1H, OH), 5.76 (d, *J* = 17.3 Hz, 1H, CH~2~), 5.95 (d, *J* = 17.3 Hz, 1H, CH~2~), 6.62 (s, 1H, OH), 7.04 (d, *J* = 7.2 Hz, 1H, arom), 7.25 (t, *J* = 7.8 Hz, 1H, arom), 7.47--7.78 (m, 7H, arom), 7.78--7.83 (m, 2H, arom), 7.93--8.03 (m, 3H, arom), 8.31 (d, *J* = 8.4 Hz, 1H, arom); ^13^C NMR (75 MHz, DMSO-*d*~6~) δ 44.8, 84.8, 96.3, 96.4, 112.9, 122.8, 123.4, 123.6, 125.5, 125.8, 125.9, 126.0, 126.3, 126.6, 127.1, 129.0, 130.4, 131.1, 131.6, 132.5, 133.4, 133.8, 135.3, 136.3, 147.4, 158.5, 177.2, 180.3, 197.2; MS (EI, 70 eV): *m*/*z* (%) = 473 (M+, 6), 332 (22), 272 (8), 185 (7), 141 (100), 76 (16).

The Supporting Information is available free of charge at [https://pubs.acs.org/doi/10.1021/acsomega.0c01934](https://pubs.acs.org/doi/10.1021/acsomega.0c01934?goto=supporting-info).NMR, HRMS, and IR spectra of all compounds ([PDF](http://pubs.acs.org/doi/suppl/10.1021/acsomega.0c01934/suppl_file/ao0c01934_si_001.pdf))Crystallographic data of compound **2a-1** ([CIF](http://pubs.acs.org/doi/suppl/10.1021/acsomega.0c01934/suppl_file/ao0c01934_si_002.cif))Crystallographic data of compound **2a-2** ([CIF](http://pubs.acs.org/doi/suppl/10.1021/acsomega.0c01934/suppl_file/ao0c01934_si_003.cif))
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